Clinical Trials
Community Health Works
A Regional Center for Health Innovation
  • Register

Clinical Trials

 

NCT ID Protocol IDs CancerType Trial Name Treatment Sites
NCT01000753 COG-ANHL04B1
ANHL04B1
Lymphoma Data and Specimen Registry of Patients With Rare or Cutaneous Non-Hodgkin Lymphoma Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT01371981 COG-AAML1031
AAML1031
Leukemia Phase II/III Randomized Study of Bortezomib and Sorafenib Tosylate in Patients With De Novo Acute Myeloid Leukemia With or Without High Allelic Ratio FLT3/ITD Mutations Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT00882609 AMI-2008-01 Prostate Cancer 18F-Fluoride PET/CT Versus 99mTc-MDP Scanning for Detecting Bone Metastases: A Randomized, Multi-Center Trial to Compare Two Bone Imaging Techniques  
NCT01270321 WCI1777-09 Skin Cancer (Non-Melanoma) A 3-Arm Randomized Phase II Trial Evaluating Single Agent and Combined Efficacy of Pasireotide and Everolimus in Adult Patients With Radioiodine-Refractory Differentiated and Medullary Thyroid Cancer Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01592045 DIV-NB-201 Neuroblastoma A Comparative Pharmacokinetic and Safety Study of Chimeric Monoclonal Antibody ch14.18 With Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF), Interleukin-2 (IL-2) and Isotretinoin in High Risk Neuroblastoma Patients Following Myeloablative Therapy Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853

 
NCT01262651 GWCA0958
2009-016064-36
Unknown Primary A Double Blind, Randomized, Placebo Controlled, Parallel Group Study of Sativex® in Relieving Persistent Pain in Patients With Advanced Cancer, Who Experience Inadequate Analgesia During Optimized Chronic Opioid Therapy.  
NCT01361607 GWCA0962
2009-016065-29
Non-Hodgkin Lymphoma A Double Blind, Randomized, Placebo-controlled, Parallel Group Study of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Relieving Uncontrolled Persistent Chronic Pain in Patients With Advanced Cancer, Who Experience Inadequate Analgesia During Optimized Chronic Opioid Therapy  
NCT01081262 NCI-2011-02516
GOG-0241
U10CA027469
CDR0000667089
UCL-07/095
UCL-mEOC
ISRCTN83438782
EUDRACT-2008-000837-23
EU-21007
NCRI-UCL-07/095
CRUK-UCL-07/095
Ovarian Cancer A GCIG Intergroup Multicenter Phase III Trial of Open Label Carboplatin and Paclitaxel +/- NCI-Supplied Agent: Bevacizumab (NSC #704865, IND #7921) Compared With Oxaliplatin and Capecitabine +/- Bevacizumab as First Line Chemotherapy in Patients With Mucinous Epithelial Ovarian Cancer or Fallopian Tube Cancer (MEOC) Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393

 
NCT01289054 CSTI571A2403 Leukemia A Global Imatinib and Nilotinib Pregnancy Exposure Registry A Post-Authorisation Safety Study (PASS)  
NCT01556282 00015167 Liver Cancer A Humanitarian Device Exemption Treatment Protocol of TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma in Patients With Portal Vein Thrombosis Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01281852 NCI-2011-02661
GOG-0076HH
U10CA027469
CDR0000693745
Cervical Cancer A Limited Access Phase I/II Trial of Paclitaxel, Cisplatin and CTEP Supplied Agent ABT-888 (Veliparib) (IND#77840, NSC#737664) in the Treatment of Advanced, Persistent, or Recurrent Carcinoma of the Cervix Georgia Health Sciences University Cancer Center
Augusta
706-721-5557

 
NCT01351545 10-CBA Multiple Primaries A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451


Northside Hospital Cancer Institute
Atlanta
404-303-3355


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01464034 AMyC 10-MM-01
IST-CAR-521
PO-MM-PI-0034
Multiple Myeloma A Multi-Center Phase I/II, Open-Label, Dose-Finding Pilot Study of the Combination of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00948636 06-DON Quality of Life A Multicenter Study of Hematopoietic Stem Cell Donor Safety and Quality of Life Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01143181 CMX001-350
1986
Bone and Soft Tissue (including Sarcoma) A Multicenter, Open-Label Study of CMX001 Treatment of Serious Diseases or Conditions Caused By dsDNA Viruses  
NCT00131313 POI-02818
NIP-02-005
Leukemia A Multicenter, Open-Label Study of Nipent, Cytoxan and Rituxan in Patients With Previously Untreated or Treated Chronic Lymphocytic Leukemia. Augusta Oncology Associates - St. Sebastian Way
Augusta
706-821-2944


Spalding Oncology Service
Griffin

 
NCT01555710 IPM3002 Lung Cancer A Multi-center, Open-Label, Adaptive, Randomized Study of Palifosfamide-tris, a Novel DNA Crosslinker, in Combination With Carboplatin and Etoposide (PaCE) Chemotherapy Versus Carboplatin and Etoposide (CE) Alone in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer. The MATISSE Study Peachtree Hematology-Oncology Consultants, PC - Atlanta
Atlanta
678-298-3235


Peachtree Hematology-Oncology Consultants, PC - Fayetteville
Fayetteville

 
NCT01234935 TRIO-TORI PA-01
NCI-2010-02190
Pancreatic Cancer A Multicenter, Open-Label, Randomized, Phase II Trial of Adjuvant Dasatinib Plus Gemcitabine Versus Single-Agent Gemcitabine in Patients With Resected Pancreatic Adenocarcinoma Northwest Georgia Oncology Centers, PC - Austell
Austell


Northwest Georgia Oncology Centers, PC - Carrollton
Carrollton


Northwest Georgia Oncology Centers, PC - Cartersville
Cartersville


Northwest Georgia Oncology Centers, PC - Douglasville
Douglasville


Northwest Georgia Oncology Centers, PC - Marietta
Marietta
770-281-5131


Suburban Hematology-Oncology Associates, PC - Duluth
Duluth


Suburban Hematology-Oncology Associates, PC - Lawrenceville
Lawrenceville
678-533-1559


Suburban Hematology-Oncology Associates, PC - Snellville
Snellville

 
NCT01314118 CR017932
Protocol 212082PCR2005
Prostate Cancer A Multicenter, Open-label, Single-arm, Phase 2 Study of Abiraterone Acetate Plus Prednisone in Subjects With Advanced Prostate Cancer Without Radiographic Evidence of Metastatic Disease  
NCT01597778 715
2U10HL069294-11
Leukemia A Multi-Center, Phase III, Randomized Trial of Reduced Intensity (RIC) Conditioning and Transplantation of Double Unrelated Umbilical Cord Blood (dUCB) Versus HLA-Haploidentical Related Bone Marrow (Haplo-BM) for Patients With Hematologic Malignancies (BMT CTN #1101) Blood and Marrow Transplant Program at Northside Hospital Cancer Institute
Atlanta
404-255-1930


Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT01271959 PT-207 Multiple Primaries A Multicenter, Post-Market Follow-up Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT01140347 13895
2010-019318-26
CP12-0919
I4T-IE-JVBF
Liver Cancer A Multicenter, Randomized, Double-Blind, Phase 3 Study of Ramucirumab (IMC-1121B) Drug Product and Best Supportive Care (BSC) Versus Placebo and BSC as Second-Line Treatment in Patients With Hepatocellular Carcinoma Following First-Line Therapy With Soraf  
NCT01602224 14199
H9S-MC-JDCG
Multiple Myeloma A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study of Tabalumab in Combination With Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma  
NCT00078598 CCBX001-049 Non-Hodgkin Lymphoma A Multi-Center, Randomized, Phase III Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Relapsed Follicular Non-Hodgkin's Lymphoma  
NCT00179647 CC-5013-MM-016
FHCRC-2068.00
CELGENE-CC-5013-MM-016
Multiple Myeloma A Multicenter, Single-Arm Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma  
NCT00882596 S07-002
1098558
Breast Cancer A Multi-Site, Prospective, Non-Randomized Study of the Contura™ Multi-Lumen Balloon (MLB) Catheter to Deliver Accelerated Partial Breast Irradiation: Analysis of Dosimetry, Local Tumor Control, Cosmetic Outcome, and Toxicity Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT01031225 9090-06 Lung Cancer A Non-Randomized, Open-label, Multi-Center, Multi-Cohort Phase 2 Study Evaluating the Efficacy and Safety of STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer  
NCT01304784 MM-111-01-01-03 Unknown Primary A Phase 1 and Pharmacologic Study of MM-111 in Combination With Multiple Treatment Regimens in Patients With Advanced HER2 Positive Solid Tumors
Atlanta
404-256-4777

 
NCT01473095 ARQ 092-101 Multiple Primaries A Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors
Atlanta
404-256-4777

 
NCT01204164 TG02-101 Non-Hodgkin Lymphoma A Phase 1 Dose-Escalation and Pharmacokinetic Study of TG02 Citrate in Patients With Advanced Hematological Malignancies Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01603979 AV-203-12-101 Unknown Primary A Phase 1 Open-label, Multiple Dose, Dose Escalation Study of Monoclonal Antibody AV-203 Administered in Subjects With Metastatic or Advanced Solid Tumors  
NCT01340976 13131
I3S-MC-JABA
Non-Hodgkin Lymphoma A Phase 1 Safety Study of LY2787106 in Patients With Cancer and Anemia  
NCT01110473 M10-943 Leukemia A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-348 in Subjects With Advanced Hematologic Malignancies Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01287546 13298
I4C-MC-JTBA
Non-Hodgkin Lymphoma A Phase 1 Study of LY2875358 in Patients With Advanced Cancer  
NCT01733004 MM-141-01-01-01 Unknown Primary A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors  
NCT01725191 NCI-2012-02163
U01CA097452
ADVL1111
Unknown Primary A Phase 1 Study of the c-Met Inhibitor, Tivantinib (ARQ 197, IND# 112603) in Children With Relapsed or Refractory Solid Tumors Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853

 
NCT01709435 NCI-2012-01890
ADVL1211
U01CA097452
Unknown Primary A Phase 1 Study of XL184 (Cabozantinib, IND# 116059) in Children and Adolescents With Recurrent or Refractory Solid Tumors, Including CNS Tumors Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853

 
NCT01693562 CD-ON-MEDI4736-1108 Kidney Cancer A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4736 in Subjects With Advanced Solid Tumors  
NCT01497093 CC-4047-MM-005 Multiple Myeloma A Phase 1, Multicenter, Open-Label, Dose-escalation Study to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide, Bortezomib and Low-Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00729664 MDX1105-01
CA210-001
Multiple Primaries A Phase 1, Multidose Study of BMS-936559 (MDX-1105) Administered Every 14 Days in Subjects With Selected Advanced or Recurrent Solid Tumors Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00304525 CHIR-265-MEL01
CHIRON-265-MEL01
CHIRON-CHIR-265-MEL01
UPCC-03605
UPCC-804245
Melanoma A Phase 1, Open-Label, Dose-Escalation Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of CHIR-265 Administered Orally to Subjects With Locally Advanced or Metastatic Melanoma Georgia Health Sciences University - CCRU
Augusta

 
NCT01183364 9090-07 Multiple Primaries A Phase 1, Pharmacokinetic Study of STA-9090 in Combination With Docetaxel in Subjects With Advanced Solid Tumor Malignancies Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01455532 TED11746
U1111-1118-6091
Unknown Primary A Phase 1/1b Dose Escalation Study Evaluating Iniparib (BSI201/SAR240550) as a Single Agent and in Combination With Chemotherapeutic Regimens in Patients With Solid Tumors  
NCT01323751 ACY-100 Multiple Myeloma A Phase 1/2, Open-Label, Multicenter Study of ACY-1215 Administered Orally as Monotherapy and in Combination With Bortezomib and Dexamethasone for the Treatment of Relapsed or Relapsed/Refractory Multiple Myeloma Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01718899 2010-001 Multiple Myeloma A Phase 1/2a Dose Escalation Study of PVX-410, a Multi-Peptide Cancer Vaccine, in Patients With Smoldering Multiple Myeloma Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00994123 MM-121-01-101 (ARD11585) Lung Cancer A Phase 1-2 Trial of MM-121 in Combination With Erlotinib in Three Groups of Patients With Non-Small Cell Lung Cancer  
NCT01410513 TCD12012
U1111-1119-2906
Non-Hodgkin Lymphoma A Phase 1b, Multicenter, Open-Label, Dose Escalation Study of SAR245409 to Evaluate the Safety, Tolerability and Clinical Activity of SAR245409 in Combination With Bendamustine and/or Rituximab in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia  
NCT01644253 16009 Leukemia A Phase 1b, Single-Arm, Open Label Study to Evaluate the Safety and Efficacy of TRU-016 in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia  
NCT01722292 14631
I4J-MC-HHBE
2012-003174-83
Lung Cancer A Phase 1b/2 Double-Blind Randomized Trial of the Hedgehog/SMO Antagonist LY2940680 in Combination With Carboplatin and Etoposide Followed by LY2940680 Versus Carboplatin and Etoposide Plus Placebo Followed by Placebo in Patients With Extensive-Stage Small Cell Lung Cancer  
NCT01188681 16201 Leukemia A Phase 1b/2 Open Label Study to Evaluate the Safety and Efficacy of TRU-016 in Combination With Bendamustine vs. Bendamustine Alone in Patients With Relapsed Chronic Lymphocytic Leukemia Georgia Health Sciences University - CCRU
Augusta

 
NCT01446159 CD-ON-MEDI-573-1030 Breast Cancer A Phase 1b/2 Randomized Study of MEDI-573 in Combination With an Aromatase Inhibitor (AI) Versus AI Alone in Women With Metastatic Breast Cancer (MBC) Northeast Georgia Cancer Care, LLC - Athens Medical Oncology
Athens
706-353-2990


Suburban Hematology-Oncology Associates, PC - Duluth
Duluth


Suburban Hematology-Oncology Associates, PC - Lawrenceville
Lawrenceville
678-533-1559


Suburban Hematology-Oncology Associates, PC - Snellville
Snellville

 
NCT00089635 20030250
UCLA-0410011-01
AMGEN-20030250
Colon/Rectal Cancer A Phase 2 Multicenter Single Arm Clinical Trial of ABX-EGF Monotherapy in Subjects with Metastatic Colorectal Cancer Whose Tumors Express Low or Negative EGFr Levels of Immunohistochemistry Following Treatment with Fluoropyrimidine, Irinotecan, and Oxalip  
NCT01395758 ARQ 197-218 Lung Cancer A Phase 2 Randomized Open-label Study of Erlotinib Plus Tivantinib (ARQ 197) Versus Single Agent Chemotherapy in Previously Treated KRAS Mutation Positive Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer  
NCT01673386 AV-951-12-205 Kidney Cancer A Phase 2 Randomized, Double-Blind, Crossover, Controlled, Multi-Center Subject Preference Study of Tivozanib Hydrochloride Versus Sunitinib in the Treatment of Subjects With Metastatic Renal Cell Carcinoma Peachtree Hematology-Oncology Consultants, PC - Atlanta
Atlanta
678-298-3235


Peachtree Hematology-Oncology Consultants, PC - Fayetteville
Fayetteville


Phoebe Cancer Center at Phoebe Putney Memorial Hospital
Albany
800-572-1932

 
NCT01479465 GS-US-295-0203 Colon/Rectal Cancer A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GS-6624 Combined With FOLFIRI as Second Line Treatment for Metastatic KRAS or BRAF Mutant Colorectal Adenocarcinoma That Has Progressed Following a First L Peachtree Hematology-Oncology Consultants, PC - Atlanta
Atlanta
678-298-3235


Peachtree Hematology-Oncology Consultants, PC - Fayetteville
Fayetteville


Suburban Hematology-Oncology Associates, PC - Duluth
Duluth


Suburban Hematology-Oncology Associates, PC - Lawrenceville
Lawrenceville
678-533-1559


Suburban Hematology-Oncology Associates, PC - Snellville
Snellville

 
NCT01745367 AV-951-12-204
2012-003507-35
Breast Cancer A Phase 2 Randomized, Double-Blind, Placebo-Controlled, 2-Arm, Multi-center Study Comparing Tivozanib Hydrochloride in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel in the Treatment of Subjects With Locally Recurrent and/or Metastatic Triple Negative Breast Cancer  
NCT01472198 GS-US-324-0101 Pancreatic Cancer A Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine as First Line Treatment for Metastatic Pancreatic Adenocarcinoma
Atlanta
404-256-4777

 
NCT01421667 SGN35-012 Lymphoma A Phase 2 Study of Brentuximab Vedotin in Relapsed or Refractory CD30-positive Non-Hodgkin Lymphoma (NHL) Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01403636 ARD12130
2011-001616-57
U1111-1118-6417
Leukemia A Phase 2 Study of SAR245409 in Patients With Relapsed or Refractory Mantle Cell Lymphoma, Follicular Lymphoma, or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma  
NCT01013324 XL147-201 Endometrial Cancer A Phase 2 Study of XL147 in Subjects With Advanced or Recurrent Endometrial Cancer Georgia Health Sciences University - CCRU
Augusta

 
NCT01358734 CC-5013-AML-001 Leukemia A Phase 2, Multicenter, Randomized, Open-label, Parallel-group Study of a Lenalidomide (Revlimid®) Regimen or a Sequential Azacitidine (Vidaza®) Plus Lenalidomide (Revlimid®) Regimen Versus an Azacitidine (Vidaza®) Regimen for Therapy of Older Subjects With Newly Diagnosed Acute Myeloid Leukemia  
NCT01599949 CR100847
PCI-32765MCL2001
2012-000711-88
Non-Hodgkin Lymphoma A Phase 2, Multicenter, Single-Arm, Study to Evaluate the Efficacy and Safety of Single-Agent Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Subjects With Mantle Cell Lymphoma Who Progress After Bortezomib Therapy  
NCT01687244 rAd-IFN-CS-002 Bladder Cancer A Phase 2, Randomized, Open Label, Parallel Arm Study to Evaluate the Safety and Efficacy of rAd-IFN/Syn3 Following Intravesical Administration in Subjects With High Grade, BCG Refractory or Relapsed Non-Muscle Invasive Bladder Cancer (NMIBC) Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01716806 SGN35-015 Hodgkin Lymphoma A Phase 2, Single-arm, Open-label Study of Single-agent Brentuximab Vedotin for Front-line Therapy of Hodgkin Lymphoma (HL) in Adults Age 60 and Above
Atlanta
404-256-4777

 
NCT01197560 CC-5013-DLC-001 Non-Hodgkin Lymphoma A Phase 2/3 Multicenter, Randomized Open-Label Study to Compare the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Investigator's Choice in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01493505 20101129
TRINOVA-3 20101129/ENGOT-ov2
Ovarian Cancer A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers  
NCT01650805 AP24534-12-301 Leukemia A Phase 3 Randomized,Open-Label Study of Ponatinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase  
NCT01510184 SPI-ZEV-11-301 Non-Hodgkin Lymphoma A Phase 3, Open-label, Multicenter, Randomized Study of Sequential Zevalin (Ibritumomab Tiuxetan) Versus Observation in Patients at Least 60 Years of Age With Newly Diagnosed Diffuse Large B-cell Lymphoma in PET-negative Complete Remission After R-CHOP or R-CHOP-like Therapy  
NCT01191801 VOS-AML-301
2010-021961-61
Leukemia A Phase 3, Randomized, Controlled, Double-Blind, Multinational Clinical Study of the Efficacy and Safety of Vosaroxin and Cytarabine Versus Placebo and Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (VALOR) Georgia Health Sciences University - CCRU
Augusta

 
NCT01605227 XL184-307
2012-001834-33
Prostate Cancer A Phase 3, Randomized, Double-blind, Controlled Study of Cabozantinib (XL184) Versus Prednisone in Metastatic Castration-resistant Prostate Cancer Patients Who Have Received Prior Docetaxel and Prior Abiraterone or MDV3100 Peachtree Hematology-Oncology Consultants, PC - Atlanta
Atlanta
678-298-3235


Peachtree Hematology-Oncology Consultants, PC - Fayetteville
Fayetteville

 
NCT01564537 C16010
2011-005496-17
Multiple Myeloma A Phase 3, Randomized, Double-Blind, Multicenter Study Comparing Oral MLN9708 Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Relapsed and/or Refractory Multiple Myeloma Northwest Georgia Oncology Centers, PC - Marietta
Marietta
770-281-5131

 
NCT00907205 SF1126-001-06 Multiple Primaries A Phase I Open Label Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation Study of SF1126, A PI3 Kinase (PI3K) Inhibitor, Given Twice Weekly By IV Infusion To Patients With Advanced or Metastatic Tumors  
NCT01273155 110060
11-C-0060
Multiple Primaries A Phase I Pharmacokinetic Study of Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01411267 T2009-004 Leukemia A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT00885326 CDR0000638257
P01CA081403
NANT2007-02
NANT-N2007-02
N2007-02
Neuroblastoma A Phase I Study of Bevacizumab With Bolus and Metronomic Cyclophosphamide and Zoledronic Acid in Children With Recurrent or Refractory Neuroblastoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01470209 WCI1925-10 Unknown Primary A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies  
NCT01485835 WCI2005-11/MMRC037 Multiple Myeloma A Phase I Study of Ganetespib +/- Bortezomib in Patients With Relapsed and/or Refractory Multiple Myeloma Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00646230 CDR0000584267
NANT-2004-03
Neuroblastoma A Phase I Study of Intravenous (Emulsion) Fenretinide in Children With Recurrent or Resistant Neuroblastoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01125800 CLDE225X2104
EUDRACT 2010-019348-37
Brain Cancer A Phase I Study of LDE225 in Pediatric Patients With Recurrent or Refractory Medulloblastoma, or Other Tumors Potentially Dependent on Hedgehog Signaling Pathway Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01711554 NCI-2012-02011
NANT N2011-04
P01CA081403
Neuroblastoma A Phase I Study of Lenalidomide and Anti-GD2 Mab Ch14.18 +/- Isotretinoin in Patients With Refractory/Recurrent Neuroblastoma. Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853

 
NCT01504776 CLBH589BUS48T Non-Hodgkin Lymphoma A Phase I Study of Panobinostat in Combination With Bortezomib in the Treatment of Relapsed and/or Refractory Mantle Cell Lymphoma  
NCT00957320 Sirolimus Acute Lymphoblastic Leukemia A Phase I Study of Sirolimus With PEG-Asparaginase in Multiple Recurrent or Refractory Childhood Acute Lymphoblastic Leukemia  
NCT01549431 WCI2011-11/MMRC036 Multiple Myeloma A Phase I Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed and/or Refractory Multiple Myeloma Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01576406 A8081012 Non-Hodgkin Lymphoma A Phase I Study To Evaluate The Effect Of Hepatic Impairment On The Pharmacokinetics And Safety Of Crizotinib In Advanced Cancer Patients  
NCT01319864 POETIC Plerixafor Multiple Primaries A Phase I Study Using Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT00981799 T2008-002 Leukemia A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01005979 WCI1642-09 Leukemia A Phase I Trial Using Cyclophosphamide, Rituximab and Revlimid (CR2) for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) and SLL  
NCT00944905 MDX1203-01
CA211-001
Non-Hodgkin Lymphoma A Phase I, Multicenter, Open-Label, Dose-Escalation, Multidose Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma or Relapsed/Refractory B-Cell Non Hodgkin's Lymphoma  
NCT01325558 CA-ALT-836-02-10 Multiple Primaries A Phase I, Open-Label, Multi-center, Competitive Enrollment and Dose-escalation Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01101594 IM-T-hLL1-DOX-01 Multiple Myeloma A Phase I/II Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple Myeloma
Lithonia



Marietta



Macon



Atlanta
404-256-4777



Decatur

 
NCT00790842 PrE1003
RV-MM-PrECOG-0394
MAYO-MC0885
MC0885
MAYO-08-003156
CELGENE-RV-MM-PI-0394
Multiple Myeloma A Phase I/II Study of the Tolerability of Lenalidomide and Low Dose Dexamethasone in Previously Treated Multiple Myeloma Patients With Impaired Renal Function  
NCT00372905 NU 05H9
STU00004871
NU-0522-060
MILLENNIUM-NU-05H9
Non-Hodgkin Lymphoma A Phase I/II Trial of Combined Weekly Bortezomib (VELCADE®) and Y-90-Ibritumomab Tiuxetan (Zevalin) in Patients With Relapsed or Refractory Follicular Lymphoma and Transformed Non-Hodgkin's Lymphoma Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00766116 090516 Leukemia A Phase I/II Trial of the Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed AML Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT00972478 NCI-2011-01964
S0806
U10CA032102
CDR0000653803
SWOG-S0806
Non-Hodgkin Lymphoma A Phase I/II Trial of Vorinostat (SAHA) (NSC-701852) in Combination With Rituximab-CHOP in Patients With Newly Diagnosed Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL) Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT00634179 IRB# 29960007 Lymphoma A Phase I/II Trial of VR-CHOP for Patients With Untreated Follicular Lymphoma and Other Low Grade B-Cell Lymphomas Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01001442 975 Multiple Myeloma A Phase I/IIa Multi-Dose Escalation Study to Evaluate Maximum Tolerated Dose (MTD), Pharmacokinetics (PK), Safety and Efficacy of BT062 in Subjects With Relapsed or Relapsed/Refractory Multiple Myeloma  
NCT01283334 WCI1761-09 Oral Cancer A Phase I/IIB Study of Combination Weekly Carboplatin, Cetuximab and Dose Escalation of RAD001 in Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01428492 115125 Multiple Myeloma A Phase Ib Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Activity of the Oral AKT Inhibitor GSK2110183 Administered in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma  
NCT01326871 CA-ALT-801-01-10 Bladder Cancer A Phase Ib/II Trial of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer  
NCT01122901 CDR0000672628
U01CA137443
ABTC-0906
Brain Cancer A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma  
NCT01705691 NSABP FB-9 Breast Cancer A Phase II Randomized Clinical Trial Evaluating Neoadjuvant Chemotherapy Regimens With Weekly Paclitaxel or Eribulin Followed by Doxorubicin and Cyclophosphamide in Women With Locally Advanced HER2-Negative Breast Cancer Phoebe Cancer Center at Phoebe Putney Memorial Hospital
Albany
800-572-1932

 
NCT00777036 CA180-226
2008-002260-33
Leukemia A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01226719 SCRI GI 134 Colon/Rectal Cancer A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection, in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only Longstreet Cancer Center, PC
Gainesville


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa

 
NCT00515411 06-103 Stomach/ Gastric Cancer A Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Patients With Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma  
NCT01182610 ACORN ARCHESO0611 Colon/Rectal Cancer A Phase II Study of Pre-operative Panitumumab, Paclitaxel, Carboplatin and Continuous Infusion 5FU in the Treatment of Potentially Resectable Gastroesophageal Adenocarcinoma  
NCT01498328 CDX110-06 Brain Cancer A Phase II Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Atlanta Cancer Care - Alpharetta
Alpharetta
404-851-2359


Atlanta Cancer Care - Conyers
Conyers


Atlanta Cancer Care - Cumming
Cumming


Atlanta Cancer Care - Decatur
Decatur


Atlanta Cancer Care - Perimeter
Atlanta
404-851-2359


Atlanta Cancer Care - Stockbridge
Lake Spivey

 
NCT00081783 XT009 Lymphoma A Phase II Study of Xcellerated T CellsTM in Patients With Relapsed or Refractory Indolent Non-Hodgkin’s Lymphoma (NHL)  
NCT01042288 SCRI LUN 183 Lung Cancer A Phase II Trial of Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type Non-Small-Cell Lung Cancer Longstreet Cancer Center, PC
Gainesville


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa

 
NCT01012609 09-014 Brain Cancer A Phase II Trial of External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas (POE08-01)  
NCT01334710 WCI1887-10 Liver Cancer A Phase II Trial of OSI-906 and Sorafenib in Advanced Hepatocellular Cancer  
NCT01188096 Poly ICLC Brain Cancer A Phase II Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade Gliomas Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01244906 NSH 911 Multiple Primaries A Phase II Trial of Post-Transplant Cyclophosphamide and Sirolimus for Graft-versus-host Disease (GVHD) Prophylaxis Following Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT01028001 UMCC 2009.008
HUM%26957
Thyroid Cancer A Phase II Trial of Preoperative Soy Isoflavone Supplementation and Molecular Markers in the Prevention of Head and Neck Squamous Carcinoma Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01490866 SCRI GI 154 Colon/Rectal Cancer A Phase II Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC) Longstreet Cancer Center, PC
Gainesville


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa

 
NCT01336712 NSH 922 Hematologic Malignancies A Phase II Trial of Total Body Irradiation-Based Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched Peripheral Blood Stem Cells for Patients With Hematologic Malignancies Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT01437566 GDC4950g
GO00769
Breast Cancer A Phase II, Double-Blind, Placebo Controlled, Randomized Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Patients Resistant to Aromatase Inhibitor Therapy Northwest Georgia Oncology Centers, PC - Austell
Austell


Northwest Georgia Oncology Centers, PC - Carrollton
Carrollton


Northwest Georgia Oncology Centers, PC - Cartersville
Cartersville


Northwest Georgia Oncology Centers, PC - Douglasville
Douglasville


Northwest Georgia Oncology Centers, PC - Marietta
Marietta
770-281-5131

 
NCT01493843 GO27912 Lung Cancer A Phase II, Double-Blind, Placebo-Controlled, Randomized Study Evaluating the Safety and Efficacy Of Carboplatin/Paclitaxel And Carboplatin/Paclitaxel/Bevacizumab With and Without GDC-0941 in Patients With Previously Untreated Advanced Or Recurrent Non-sm Peachtree Hematology-Oncology Consultants, PC - Atlanta
Atlanta
678-298-3235


Peachtree Hematology-Oncology Consultants, PC - Fayetteville
Fayetteville

 
NCT01523171 ARD12181
2011-005226-21
U1111-1124-0967
Myelodysplastic Syndromes (MDS) A Phase II, Multicenter, Open Label, Single Arm Study of SAR302503 in Subjects Previously Treated With Ruxolitinib and With a Current Diagnosis of Intermediate-2 or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis  
NCT01201915 SHH4812g
GS01354
Skin Cancer (Non-Melanoma) A Phase II, Multicenter, Open-Label, Two-Cohort Trial Evaluating the Efficacy and Safety of GDC-0449 in Operable Basal Cell Carcinoma (BCC)  
NCT01685060 CLDK378A2201
2012-003432-24
Lung Cancer A Phase II, Multicenter, Single-arm Study of Oral LDK378 in Adult Patients With ALK-activated Non-small Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01414855 GAO4915g
BO25324
Non-Hodgkin Lymphoma A Phase II, Open-Label, Multicenter Study of Efficacy, Safety, and Biomarkers in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma Treated With GA101 (RO5072759) in Combination With CHOP Chemotherapy Northwest Georgia Oncology Centers, PC - Austell
Austell


Northwest Georgia Oncology Centers, PC - Carrollton
Carrollton


Northwest Georgia Oncology Centers, PC - Cartersville
Cartersville


Northwest Georgia Oncology Centers, PC - Douglasville
Douglasville


Northwest Georgia Oncology Centers, PC - Marietta
Marietta
770-281-5131

 
NCT01106833 609
BMT CTN 0801
U01HL069294-06
Bone and Soft Tissue (including Sarcoma) A Phase II/III Randomized, Multicenter Trial Comparing Sirolimus Plus Prednisone, Sirolimus/Extracorporeal Photopheresis Plus Prednisone, and Sirolimus/Calcineurin Inhibitor Plus Prednisone for the Treatment of Chronic Graft-versus-Host Disease (BMT CTN # Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451


Northside Hospital Cancer Institute
Atlanta
404-303-3355


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
    Breast Cancer A Phase III Double Blind Study On The Efficacy of Topical Aloe Vera Gel on Irradiated Breast Tissue Lewis Hall Singletary Oncology Center at John D. Archbold Memorial Hospital
Thomasville

 
    Breast Cancer A Phase III Double Blind Study On The Efficacy of Topical Aloe Vera Gel on Irradiated Breast Tissue  
NCT01303796 CYC682-12 Leukemia A Phase III Randomized Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia Northside Hospital Cancer Institute
Atlanta
404-303-3355


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01101438 MA32
U10CA077202
CAN-NCIC-MA.32
CDR0000669788
NCIC-MA.32
Breast Cancer A Phase III Randomized Trial of Metformin Versus Placebo on Recurrence and Survival in Early Stage Breast Cancer Longstreet Cancer Center, PC
Gainesville


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


Pearlman Comprehensive Cancer Center at South Georgia Medical Center
Valdosta
229-259-4628


Phoebe Cancer Center at Phoebe Putney Memorial Hospital
Albany
800-572-1932


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa

 
NCT01610284 CBKM120F2302
2011-005524-17
Breast Cancer A Phase III Randomized, Double Blind Placebo Controlled Study of BKM120 With Fulvestrant, in Postmenopausal Women With Hormone Receptor-positive HER2-negative Locally Advanced or Metastatic Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment  
NCT01419197 TDM4997g
2011-000509-29
BO25734
Breast Cancer A Phase III Randomized, Multicenter, Two-Arm, Open-Label Trial to Evaluate the Efficacy of Trastuzumab Emtansine Compared With Treatment of Physician's Choice in Patients With HER2 Positive Metastatic Breast Cancer Who Have Received at Least Two Prior Reg Northwest Georgia Oncology Centers, PC - Austell
Austell


Northwest Georgia Oncology Centers, PC - Carrollton
Carrollton


Northwest Georgia Oncology Centers, PC - Cartersville
Cartersville


Northwest Georgia Oncology Centers, PC - Douglasville
Douglasville


Northwest Georgia Oncology Centers, PC - Marietta
Marietta
770-281-5131

 
NCT01254630 V212-011 Multiple Primaries A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients With Solid Tumor or Hematologic Malignancy Dublin Hematology and Oncology Care
Dublin
478-275-1111


Peachtree Hematology-Oncology Consultants, PC - Atlanta
Atlanta
678-298-3235


Peachtree Hematology-Oncology Consultants, PC - Fayetteville
Fayetteville

 
NCT01414608 CDR0000706698
ANZGOG-0902-GOG-0274/RTOG-1174
ANZGOG-0902-GOG-0274
Cervical Cancer A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial Central Georgia Gynecologic Oncology
Macon
476-633-6090


Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT01287741 BO21005
2010-024194-39
Non-Hodgkin Lymphoma A Phase III, Multicenter, Open-label Randomized Trial Comparing the Efficacy of GA101 (RO5072759) in Combination With CHOP (G-CHOP) Versus Rituximab and CHOP (R-CHOP) in Previously Untreated Patients With CD20-positive Diffuse Large B-cell Lymphoma (DLBCL Central Georgia Cancer Care, PC - Macon
Macon


Central Georgia Cancer Care, PC - Warner Robins
Warner Robins

 
NCT01039376 112517 Leukemia A Phase III, Open Label, Randomized, Multicenter Trial of Ofatumumab Maintenance Treatment Versus no Further Treatment in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL) Who Have Responded to Induction Therapy Central Georgia Cancer Care, PC - Macon
Macon


Central Georgia Cancer Care, PC - Warner Robins
Warner Robins


Summit Cancer Care
Savannah
912-354-6187


Summit Cancer Care - Statesboro
Statesboro


Summit Cancer Care at Curtis and Elizabeth Anderson Cancer Institute
Savannah


Summit Cancer Care at the Nancy N. Lewis and J.C. Lewis Cancer & Research Pavilion
Savannah

 
NCT01663727 GO25632
2011-005335-97
Breast Cancer A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer Peachtree Hematology-Oncology Consultants, PC - Atlanta
Atlanta
678-298-3235


Peachtree Hematology-Oncology Consultants, PC - Fayetteville
Fayetteville

 
    Breast Cancer A Phase III, Single-arm, Open Label, Single Study of Topical Application of a 2 Step Radiaderm Advanced Skincare System containing LactokineTM Fluid on Radiation Dermatitis in Breast Cancer Patients Treated with Adjuvant Whole Breast Radiation Therapy  
    Breast Cancer A Phase III, Single-arm, Open Label, Single Study of Topical Application of a 2 Step Radiaderm Advanced Skincare System containing LactokineTM Fluid on Radiation Dermatitis in Breast Cancer Patients Treated with Adjuvant Whole Breast Radiation Therapy Lewis Hall Singletary Oncology Center at John D. Archbold Memorial Hospital
Thomasville

 
NCT01655875 CHOA AMD3100 Pilot Acute Myelogenous Leukemia A Pilot Study of AMD3100 as a Sensitizing Agent in Myeloablative Allogeneic Blood and Marrow Transplantation for Chemotherapy Resistant Pediatric Acute Leukemia Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853

 
NCT00967525 Intraosseous Infusion Lymphoma A Pilot Study of Intraosseous Infusion of Unrelated Cord Blood Grafts  
NCT01328873 NSH 909 Hematologic Malignancies A Prospective Assessment of the Diagnostic Utility of Emerging Laboratory Assessments Used in Conjunction With Fiberoptic Bronchoscopy (FOB) in Hematopoietic Stem Cell Transplant (HSCT) and Leukemia Patients With Acute Respiratory Symptoms and Pulmonary I Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT01137123 2007044 Head and Neck Cancer A Prospective Clinical Trial of Improving the Treatment of Thoracic Esophageal Cancer  
NCT01604252 ML28296 Skin Cancer (Non-Melanoma) A Prospective Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients  
NCT00974623 APPROACH-001 Brain Cancer A Prospective Patient Registry for Bone Graft Substitutes in Spinal Fusion: Patient Outcomes and Use in Clinical Practice  
NCT00903565 CP-060-CR Colon/Rectal Cancer A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint  
NCT01454297 MMRF-11-001 Multiple Myeloma A Prospective, Longitudinal, Observational Study in Newly Diagnosed Multiple Myeloma (MM) Patients to Assess the Relationship Between Patient Outcomes, Treatment Regimens and Molecular Profiles Atlanta Cancer Care - Alpharetta
Alpharetta
404-851-2359


Atlanta Cancer Care - Conyers
Conyers


Atlanta Cancer Care - Cumming
Cumming


Atlanta Cancer Care - Decatur
Decatur


Atlanta Cancer Care - Perimeter
Atlanta
404-851-2359


Atlanta Cancer Care - Stockbridge
Lake Spivey


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00916409 EF-14 Brain Cancer A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients With Newly Diagnosed GBM. Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00812240 AB04030 Colon/Rectal Cancer A Prospective, Multicenter, Randomized, Open-label, Active-controlled, 2-parallel Group, Phase III Study to Compare Efficacy and Safety of Masitinib at 7.5 mg/kg/Day to Imatinib at 400 or 600 mg in Treatment of Patients With Gastro-intestinal Stromal Tumo  
NCT00320710 CZOL446E2352 Breast Cancer A Prospective, Randomized, Double-blind, Stratified, Multi-center, 2-arm Trial of the Continued Efficacy and Safety of Zoledronic Acid (Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Breast Cancer John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449

 
NCT01468623 PROFUSE-2011 Colon/Rectal Cancer A Prospective, Randomized, Open-label Trial Comparing OnDose® AUC Optimized 5-FU Based Administration Versus Standard Body Surface Area (BSA) Dosing in Metastatic Colorectal Cancer Patients (mCRC) Treated With mFOLFOX6  
NCT01499303 D4302C00001 Non-Hodgkin Lymphoma A Randomised Double Blind Phase II Trial to Evaluate the Efficacy of Two Doses of Fostamatinib in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT01343277 CR018004
ET743SAR3007
Colon/Rectal Cancer A Randomized Controlled Study of YONDELIS (Trabectedin) or Dacarbazine for the Treatment of Advanced Liposarcoma or Leiomyosarcoma Previously Treated With an Anthracycline and Ifosfamide Georgia Health Sciences University - Gynecologic Oncology
Augusta

 
NCT01170650 EC-FV-06 Ovarian Cancer A Randomized Double-Blind Phase 3 Trial Comparing EC145 and Pegylated Liposomal Doxorubicin (PLD/Doxil®/Caelyx®) in Combination Versus PLD in Participants With Platinum-Resistant Ovarian Cancer Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Georgia Health Sciences University - Gynecologic Oncology
Augusta


Northside Hospital Cancer Institute
Atlanta
404-303-3355


Southeastern Gynecologic Oncology, LLC
Gainesville

 
NCT01321541 PIX306 (PIX-R Trial) Non-Hodgkin Lymphoma A Randomized Multicenter Study Comparing Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma Who Have Relapsed After Therapy With CHOP-R or an Equivalent Regimen and Are Ineligible for Stem Cell Tran Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT01358877 BO25126
2010-022902-41
BIG 04-11
TOC4939G
Breast Cancer A Randomized Multicenter, Double-blind, Placebo-controlled Comparison of Chemotherapy Plus Trastuzumab Plus Placebo Versus Chemotherapy Plus Trastuzumab Plus Pertuzumab as Adjuvant Therapy in Patients With Operable HER2-positive Primary Breast Cancer Northwest Georgia Oncology Centers, PC - Austell
Austell


Northwest Georgia Oncology Centers, PC - Carrollton
Carrollton


Northwest Georgia Oncology Centers, PC - Cartersville
Cartersville


Northwest Georgia Oncology Centers, PC - Douglasville
Douglasville


Northwest Georgia Oncology Centers, PC - Marietta
Marietta
770-281-5131


Phoebe Cancer Center at Phoebe Putney Memorial Hospital
Albany
800-572-1932

 
NCT01420081 B1271004 Endometrial Cancer A Randomized Phase 2 Non-Comparative Study Of The Efficacy Of PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer Georgia Health Sciences University - Gynecologic Oncology
Augusta

 
NCT00590187 CYC682-06 Leukemia A Randomized Phase 2 Study of Oral Sapacitabine in Elderly Patients With Acute Myeloid Leukemia Previously Untreated or in First Relapse, or Previously Treated Myelodysplastic Syndromes  
NCT01578655 OGX-011-12 Prostate Cancer A Randomized Phase 3 Study Comparing Cabazitaxel/Prednisone in Combination With Custirsen (OGX-011) to Cabazitaxel/Prednisone for Second-Line Chemotherapy in Men With Metastatic Castrate Resistant Prostate Cancer (AFFINITY)  
NCT01708941 NCI-2012-01932
E3611
U10CA021115
Melanoma A Randomized Phase II Study of Ipilimumab at 3 mg/kg or 10 mg/kg Alone or in Combination With High Dose Interferon-Alpha in Advanced Melanoma Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph's/Candler
Savannah
912-819-6204

 
NCT01231412 FHCRC2448
NCI-2010-02035
P01CA018029
2448.00
Bone and Soft Tissue (including Sarcoma) A Randomized Phase III Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD After Unrelated Donor Hematopoietic Cell Transplantation Using Nonmyeloablative Conditioning for Patients With Hematologic Malignancie Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01147809 112765 Multiple Primaries A Randomized, Blinded, Placebo-controlled, Two-Phase, Sequential Cohort, Dose Finding Study to Assess Safety and Efficacy of Eltrombopag Administered to Patients With Solid Tumors Receiving Gemcitabine Monotherapy or the Combination of Gemcitabine Plus Ca  
NCT01696032 SGI-110-02 Ovarian Cancer A Randomized, Controlled, Open-Label, Phase 2 Trial of SGI-110 and Carboplatin in Subjects With Platinum-Resistant Recurrent Ovarian Cancer Georgia Health Sciences University Cancer Center
Augusta
706-721-5557

 
NCT01265576 VT1-CAX-200 Liver Cancer A Randomized, Double Blind, Placebo Controlled, Multicenter Phase 2 Study of VT-122 in Combination With Sorafenib Compared to Sorafenib With Placebo in Patients With Hepatocellular Carcinoma and Systemic Inflammation at Risk for Cachexia  
NCT00738699 MORAb003-003PR Ovarian Cancer A Randomized, Double Blind, Placebo-Controlled Study of the Efficacy and Safety oF MORAb-003(Farletuzumab)in Combination With Paclitaxel Therapy in Subjects With Platinum-Resistant or Refractory Relapsed Ovarian Cancer  
NCT01283906 APC-10U1101 Head and Neck Cancer A Randomized, Double-blind Study to Evaluate the Efficacy of MuGard Mucoadhesive Oral Wound Rinse for the Amelioration of Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449

 
NCT01287585 POLARIS2009-001 Liver Cancer A Randomized, Double-Blind, Multi-Center Phase 3 Study of ADI-PEG 20 Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Subjects With Advanced Hepatocellular Carcinoma (HCC) Who Have Failed Prior Systemic Therapy Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853

 
NCT01183780 13856
I4T-MC-JVBB
CP12-0920
2010-021037-32
CTRI/2011/07/001900
Colon/Rectal Cancer A Randomized, Double-blind, Multicenter Phase 3 Study of Irinotecan, Folinic Acid, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab or Placebo in Patients With Metastatic Colorectal Carcinoma Progressive During or Following First-Line Combination Therapy Wit Central Georgia Cancer Care, PC - Macon
Macon


Central Georgia Cancer Care, PC - Warner Robins
Warner Robins


Harbin Clinic Cancer Center
Rome
404-851-2340


Northeast Georgia Cancer Care, LLC - Athens Medical Oncology
Athens
706-353-2990


Northwest Georgia Oncology Centers, PC - Austell
Austell


Northwest Georgia Oncology Centers, PC - Carrollton
Carrollton


Northwest Georgia Oncology Centers, PC - Cartersville
Cartersville


Northwest Georgia Oncology Centers, PC - Douglasville
Douglasville


Northwest Georgia Oncology Centers, PC - Marietta
Marietta
770-281-5131

 
NCT01345019 20090482 Multiple Myeloma A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid (Zometa®) in the Treatment of Bone Disease in Subjects With Newly Diagnosed Multiple Myeloma Summit Cancer Care
Savannah
912-354-6187


Summit Cancer Care - Statesboro
Statesboro


Summit Cancer Care at Curtis and Elizabeth Anderson Cancer Institute
Savannah


Summit Cancer Care at the Nancy N. Lewis and J.C. Lewis Cancer & Research Pavilion
Savannah

 
NCT01081041 13611
I4E-MC-JXBD
Oral Cancer A Randomized, Double-Blind, Phase 2 Safety Study of Cetuximab, Using ImClone Versus Boehringer Ingelheim Manufacturing Processes, in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First-Line Treatment of Patients With Locoregionally R Georgia Health Sciences University - CCRU
Augusta


Phoebe Cancer Center at Phoebe Putney Memorial Hospital
Albany
800-572-1932

 
NCT01288911 9785-CL-0222 Prostate Cancer A Randomized, Double-Blind, Phase II, Efficacy and Safety Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer  
NCT01186861 OSI-906-205 Lung Cancer A Randomized, Double-Blind, Placebo-controlled Phase 2 Study of Maintenance OSI 906 Plus Erlotinib (Tarceva®), or Erlotinib Plus Placebo in Patients With Nonprogression Following Four Cycles of 1st-line Platinum-based Chemotherapy for Advanced NSCLC Phoebe Cancer Center at Phoebe Putney Memorial Hospital
Albany
800-572-1932

 
NCT01235962 113387 Kidney Cancer A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Pazopanib as Adjuvant Therapy for Subjects With Localized or Locally Advanced RCC Following Nephrectomy Central Georgia Cancer Care, PC - Macon
Macon


Central Georgia Cancer Care, PC - Warner Robins
Warner Robins


Northeast Georgia Cancer Care, LLC - Athens Medical Oncology
Athens
706-353-2990

 
NCT01507545 MORAb-004-202-CRC Colon/Rectal Cancer A Randomized, Double-Blind, Placebo-controlled Study of the Efficacy & Safety of Monotherapy MORAb-004 Plus Best Supportive Care in Subjects With Chemorefractory Metastatic Colorectal Cancer  
NCT00858364 20070782 Lung Cancer A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Long-term Safety and Efficacy of Darbepoetin Alfa Administered at 500 µg Once-Every-3-Weeks in Anemic Subjects With Advanced Stage Non-small Cell Lung Cancer Receiving Multi-cycle Chemot Lewis Hall Singletary Oncology Center at John D. Archbold Memorial Hospital
Thomasville


Summit Cancer Care
Savannah
912-354-6187


Summit Cancer Care - Statesboro
Statesboro


Summit Cancer Care at Curtis and Elizabeth Anderson Cancer Institute
Savannah


Summit Cancer Care at the Nancy N. Lewis and J.C. Lewis Cancer & Research Pavilion
Savannah

 
NCT01360840 EMR 62242-006 Prostate Cancer A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Trial Investigating Two Doses of EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer (mCRPC) Georgia Health Sciences University - CCRU
Augusta

 
NCT00790036 CRAD001N2301
EUDRACT 2008-000498-40
Non-Hodgkin Lymphoma A Randomized, Double-blind, Placebo-controlled, Multi-center Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With F John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Northeast Georgia Cancer Care, LLC - Athens Medical Oncology
Athens
706-353-2990

 
NCT01521143 CAN-004 Ovarian Cancer A Randomized, Double-Blinded, Placebo-Controlled Trial of Cvac as Maintenance Treatment in Patients With EOC in CR Following First-Line Chemotherapy Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT01769391 14790
I4X-MC-JFCL
2012-003214-13
Lung Cancer A Randomized, Multicenter, Open-Label, Phase 2 Study of Paclitaxel-Carboplatin Chemotherapy Plus Necitumumab (IMC-11F8) Versus Paclitaxel-Carboplatin Chemotherapy Alone in the First-Line Treatment of Patients With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)  
NCT01578707 PCYC-1112-CA
2012-000694-23
Leukemia A Randomized, Multicenter, Open-label, Phase 3 Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Northwest Georgia Oncology Centers, PC - Marietta
Marietta
770-281-5131

 
NCT01722487 PCYC-1115-CA
2012-003967-23
Leukemia A Randomized, Multicenter, Open-label, Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 Versus Chlorambucil in Patients 65 Years or Older With Treatment-naive Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (RESONATE™-2) Peachtree Hematology-Oncology Consultants, PC - Atlanta
Atlanta
678-298-3235


Peachtree Hematology-Oncology Consultants, PC - Fayetteville
Fayetteville

 
NCT01339910 709
U01HL069294-05
0901
Hematologic Malignancies A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Blood and Marrow Transplant Program at Northside Hospital Cancer Institute
Atlanta
404-255-1930


Northside Hospital Cancer Institute
Atlanta
404-303-3355


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01494506 MM-398-07-03-01 Pancreatic Cancer A Randomized, Open Label Phase 3 Study of MM-398 Versus 5-Fluorouracil and Leucovorin in Patients With Metastatic Pancreatic Cancer  
NCT01077518 110918 Non-Hodgkin Lymphoma A Randomized, Open Label Study of Ofatumumab and Bendamustine Combination Therapy Compared With Bendamustine Monotherapy in Indolent B-cell Non-Hodgkin's Lymphoma Unresponsive to Rituximab or a Rituximab-Containing Regimen During or Within Six Months of T
Lithonia



Marietta



Macon



Atlanta
404-256-4777



Decatur

 
NCT00338286 CR005143
EPOANE3010
2005-001817-17
Breast Cancer A Randomized, Open-label, Multicenter, Phase 3 Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy  
NCT01327885 E7389-G000-309 Bone and Soft Tissue (including Sarcoma) A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00081796 XRP9881B/3001 Breast Cancer A Randomized, Open-label, Phase III Study of an Investigational Drug IV Every 3 Weeks versus Capecitabine (Xeloda) Tablets Twice Daily for 2 Weeks in 3-Week Cycles in Patients with Metastatic Breast Cancer Progressing after Taxanes and Anthracycline  
NCT01421472 MM-121-02-02-07 (ARD11918) Breast Cancer A Randomized, Phase 2 Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer
Atlanta
404-256-4777


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853

 
NCT01353222 N10-1 Bladder Cancer A Randomized, Phase 2, Open-label Study Evaluating DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma  
NCT01496742 GO27821
2011-003719-42
Lung Cancer A Randomized, Phase II, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Metmab Vs. Placebo in Combination With Either Bevacizumab + Platinum + Paclitaxel or Pemetrexed + Platinum in Patients With Untreated Stage I Suburban Hematology-Oncology Associates, PC - Duluth
Duluth


Suburban Hematology-Oncology Associates, PC - Lawrenceville
Lawrenceville
678-533-1559


Suburban Hematology-Oncology Associates, PC - Snellville
Snellville

 
NCT01519804 GO27820 Lung Cancer A Randomized, Phase II, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Onartuzumab (Metmab) in Combination With Paclitaxel + Cisplatin or Carboplatin as First-Line Treatment for Patients With Stage IIIb (T4 Disease) or IV Squamous Non-Small Cell Lung Cancer (NSCLC)  
NCT01186991 OAM4861g Breast Cancer A Randomized, Phase II, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of MetMAb in Combination With Paclitaxel and Bevacizumab in Patients With Metastatic, Triple-Negative Breast Cancer Suburban Hematology-Oncology Associates, PC - Duluth
Duluth


Suburban Hematology-Oncology Associates, PC - Lawrenceville
Lawrenceville
678-533-1559


Suburban Hematology-Oncology Associates, PC - Snellville
Snellville

 
NCT01348126 9090-08 Lung Cancer A Randomized, Phase IIB/III Study of Ganetespib (STA-9090) in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Stage IIIb or IV Non-Small-Cell Lung Cancer Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00968968 112515 Breast Cancer A Randomized, Phase III, Open-label Study of Lapatinib Plus Trastuzumab Versus Trastuzumab as Continued HER2 Suppression Therapy After Completion of First- or Second-line Trastuzumab Plus Chemotherapy in Subjects With HER2-positive Metastatic Breast Cance  
NCT01337154 TAMI-P2-NSCLC-01 Lung Cancer A Randomized, Placebo-Controlled Phase 2b Study of Tamibarotene Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin as First Line Treatment for Subjects With Advanced Non-Small Cell Lung Cancer  
NCT01116245 Lm-LLO-E7-07 Cervical Cancer A Randomized, Single Blind, Placebo Controlled Phase 2 Study to Assess the Safety of ADXS11-001 for the Treatment of Cervical Intraepithelial Neoplasia Grade 2/3 Atlanta Women's Research Institute
Atlanta
678-867-9410

 
NCT01491737 MO27775 Breast Cancer A Randomized, Two-arm, Open-label, Multicenter Phase II Trial Assessing the Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab Plus an Aromatase Inhibitor in First Line Patients With HER2-positive and Hormone Receptor-positive Advanced (Metastatic or Locally Advanced) Breast Cancer.  
    Multiple Primaries A Registry of Caris Target Now Test Results (Biomarker Expression Patterns) and Hematopoietic Diagnostics for Evaluation of Correlation with Clinical Outcomes for Cancer and other Patients  
    Multiple Primaries A Registry of Caris Target Now Test Results (Biomarker Expression Patterns) for Evaluation of Correlation with Clinical Outcomes for Cancer Lewis Hall Singletary Oncology Center at John D. Archbold Memorial Hospital
Thomasville

 
    Lung Cancer A Registry of Cesium-131 Brachytherapy Plus Sub- lobar Resection for Early Stage Lung Cancer Lewis Hall Singletary Oncology Center at John D. Archbold Memorial Hospital
Thomasville

 
NCT01306890 P10-3 Prostate Cancer A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
Atlanta
404-256-4777


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Lewis Hall Singletary Oncology Center at John D. Archbold Memorial Hospital
Thomasville


Northwest Georgia Oncology Centers, PC - Austell
Austell


Northwest Georgia Oncology Centers, PC - Carrollton
Carrollton


Northwest Georgia Oncology Centers, PC - Cartersville
Cartersville


Northwest Georgia Oncology Centers, PC - Douglasville
Douglasville


Northwest Georgia Oncology Centers, PC - Marietta
Marietta
770-281-5131


Peachtree Hematology-Oncology Consultants, PC - Atlanta
Atlanta
678-298-3235


Peachtree Hematology-Oncology Consultants, PC - Fayetteville
Fayetteville


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853

 
NCT01301417 RETROPRESS Colon/Rectal Cancer a RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing ™  
NCT01673854 CA184-240
2012-002054-24
Melanoma A Single Arm Open-Label Phase II Study of Vemurafenib Followed by Ipilimumab in Subjects With Previously Untreated V600 BRAF Mutated Advanced Melanoma Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01470248 WCI1988-11 Lung Cancer A Single Arm, Two-Stage Phase II Study of Arsenic Trioxide in Previously Treated Small Cell Lung Cancer Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01471782 MT103-205
2010-024264-18
Acute Lymphoblastic Leukemia A Single-Arm Multicenter Phase II Study Preceded by Dose Evaluation to Investigate the Efficacy, Safety, and Tolerability of the BiTE® Antibody Blinatumomab (MT103) in Pediatric and Adolescent Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL) Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853

 
NCT01248923 ARRAY-520-111 Multiple Myeloma A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00821249 ARRAY-520-212 Multiple Myeloma A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01496495 ARRAY-614-112 Myelodysplastic Syndromes (MDS) A Study of ARRY-614 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01432886 E7389-J081-107 Breast Cancer A Study of Eribulin Mesylate With Trastuzumab for Advanced or Recurrent Human Epiderma Growth Factor Receptor 2-Positive (HER2+) Breast Cancer  
NCT00952380 FRAG-A001-201 Symptom Management A Three Month Prospective Open Label Study Of Therapy With Fragmin (Dalteparin Sodium Injection) In Children With Malignancies And Venous Thromboembolism  
NCT01230788 Rituximab Acute Lymphoblastic Leukemia A Trial of Rituximab Combined With Prednisone/Ifosfamide/Etoposide for Relapsed Acute Lymphoblastic Leukemia (ALL) Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01109004 690 Multiple Myeloma A Trial of Single Autologous Transplant With or Without Consolidation Therapy Versus Tandem Autologous Transplant With Lenalidomide Maintenance for Patients With Multiple Myeloma (BMT CTN 0702) Blood and Marrow Transplant Program at Northside Hospital Cancer Institute
Atlanta
404-255-1930


Georgia Health Sciences University Cancer Center
Augusta
706-721-5557


Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT01565083 MO27782
2011-003308-18
Breast Cancer A Two-cohort, Open-label, Multicenter Phase II Trial Assessing the Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in First Line Patients With HER2-positive Advanced (Metastatic or Locally Advanced) Breast Cancer.  
NCT01370408 NSH 940 Symptom Management A Unique Schedule of Palonosetron, Ondansetron, and Dexamethasone for the Prevention of Delayed Nausea and Vomiting in Patients Receiving Moderately Emetogenic Myeloablative Chemotherapy Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT01309672 CDR0000696565
SWOG-S1014
S1014
Prostate Cancer Abiraterone Acetate Treatment for Prostate Cancer Patients With a PSA of More Than Four Following Initial Androgen Deprivation Therapy Phase II Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT01542814 FMSU2011-003A Breast Cancer Acquisition of Mammography Images for Clinical Evaluation of FUJIFILM 3Dimensional Mammography Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01666808 1R01CA169188-01 Prostate Cancer Advanced Molecular Imaging With Anti-3-[18F]FACBC PET-CT to Improve the Selection and Outcomes of Prostate Cancer Patients Receiving Post-prostatectomy Radiotherapy Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01410344 710
U01HL069294
BMT CTN 0903
Hematologic Malignancies Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodysplastic Syndromes in HIV-Infected Individuals Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT01659645 FACBCBr Breast Cancer Amino Acid Transport Imaging of Breast Carcinoma Via Anti-3-[18F]FACBC PET-CT: A Pilot Study Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01574287 51415 Unknown Primary Amino Acid Transport Imaging of Parathyroid Adenomas With Anti-3-[18F]FACBC Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01711697 IRB00056552
NCI-2012-01934
Lung Cancer An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01582672 AGS-003-007
2012-000871-17
Kidney Cancer An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)  
NCT01480479 CDX110-04 Brain Cancer An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma  
NCT01615068 ML28257 Breast Cancer An Observational Cohort Study Of Treatment Patterns And Outcomes In Patients With HER2 Positive (Her2+) Metastatic Breast Cancer (SystHERs Registry (Systematic Therapies for HER2+ Metastatic Breast Cancer Study)). Peachtree Hematology-Oncology Consultants, PC - Atlanta
Atlanta
678-298-3235


Peachtree Hematology-Oncology Consultants, PC - Fayetteville
Fayetteville

 
NCT01598597 GO28289 Breast Cancer An Observational Pilot Study Evaluating the Feasibility of Conducting Genomewide Association Studies Utilizing Subject-Provided Information in Subjects With Metastatic Breast Cancer Treated With Avastin  
NCT01348490 INCB18424-258 Myelodysplastic Syndromes (MDS) An Open Label Assessment of Safety and Efficacy of Ruxolitinib (INCB018424) in Subjects With Primary Myelofibrosis (PMF), Post Essential Thrombocythemia-myelofibrosis (PPV-MF) and Post Polycythemia Vera-myelofibrosis (PET-MF) Who Have Platelet Counts of 50 x 10^9/L to 100 x 10^9/L  
NCT01677455 9090-11 Breast Cancer An Open Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib(STA-9090) Monotherapy in Women With Previously Untreated Metastatic HER2 Positive or Triple Negative Breast Cancer  
NCT01472887 ARD10248
2011-003657-26
U1111-1115-3349
Non-Hodgkin Lymphoma An Open Label Non-Randomized Phase 2 Study Evaluating SAR3419, an Anti-CD19 Antibody - Maytansine Conjugate, Administered as Single Agent by Intravenous Infusion to Patients With Relapsed or Refractory CD19+ Diffuse Large B-Cell Lymphoma  
NCT01297491 CBKM120D2201
2010-024011-14
Lung Cancer An Open Label Two-stage Study of Orally Administered BKM120 in Patients With Metastatic Non-small Cell Lung Cancer With Activated PI3K Pathway  
NCT01466179 MT103-211
2011-002257-61
Leukemia An Open Label, Multicenter, Phase II Study to Evaluate Efficacy and Safety of the BiTE Antibody Blinatumomab in Adult Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01348490 INCB18424-258 Symptom Management An Open-Label Assessment of Safety and Efficacy of Ruxolitinib (INCB018424) in Subjects with Primary Myelofibrosis, Post Essential Thrombocythemia-Myelofibrosis and Post Polycythemia Vera-Myelofibrosis Who Have Platelet Counts of 50X10 9/L to 100 X 10 9L Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01724346 PCYC-1116-CA
2012-003968-44
Leukemia An Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Who Participated in Study PCYC-1115-CA (PCI-32765 Versus Chlorambucil) Peachtree Hematology-Oncology Consultants, PC - Atlanta
Atlanta
678-298-3235


Peachtree Hematology-Oncology Consultants, PC - Fayetteville
Fayetteville

 
NCT01331941 20090277 Unknown Primary An Open-label Pharmacokinetic Study of AMG 386 in Advanced Cancer Subjects With Normal and Impaired Renal Function  
NCT01418677 E7389-A001-106 Unknown Primary An Open-Label Phase 1 Study to Assess the Pharmacokinetics and Safety of HALAVEN™ in Subjects With Cancer Who Also Have Impaired Renal Function  
NCT01458392 A041-03 Head and Neck Cancer An Open-label Phase 2 Study of ACE-041 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck  
NCT01538680 BAYER 15967 Colon/Rectal Cancer An Open-label Phase IIIb Study of Regorafenib in Patients With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy Summit Cancer Care
Savannah
912-354-6187


Summit Cancer Care - Statesboro
Statesboro


Summit Cancer Care at Curtis and Elizabeth Anderson Cancer Institute
Savannah


Summit Cancer Care at the Nancy N. Lewis and J.C. Lewis Cancer & Research Pavilion
Savannah

 
NCT00428220 A6181114 Breast Cancer An Open-Label Sunitinib Malate (SU011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment. Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01335685 C16006
2010-023772-71
Multiple Myeloma An Open-Label, Dose-Escalation, Phase 1/2 Study of the Oral Form of MLN9708, a Next-Generation Proteasome Inhibitor, Administered in Combination With a Standard Care Regimen of Melphalan and Prednisone in Patients With Newly Diagnosed Multiple Myeloma Req Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01678690 HR-11-001 Unknown Primary An Open-Label, Exploratory, Limited Dose Escalation Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors Georgia Health Sciences University Cancer Center
Augusta
706-721-5557

 
NCT00781612 TDM4529g
BO25430
Breast Cancer An Open-Label, Multicenter Extension Study of Trastuzumab-MCC-DM1 (T-DM1) Administered as a Single Agent or in Combination With Other Anti-Cancer Therapies in Patients Previously Treated With the Equivalent T-DM1 Regimen in a Genentech and/or F. Hoffmann-La Roche Ltd.-Sponsored T-DM1 Study Northwest Georgia Oncology Centers, PC - Austell
Austell


Northwest Georgia Oncology Centers, PC - Carrollton
Carrollton


Northwest Georgia Oncology Centers, PC - Cartersville
Cartersville


Northwest Georgia Oncology Centers, PC - Douglasville
Douglasville


Northwest Georgia Oncology Centers, PC - Marietta
Marietta
770-281-5131

 
NCT01192295 OTR3001
2010-020471-23
Unknown Primary An Open-label, Multicenter Study of the Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Opioid Experienced Children From Ages 6 to 16 Years Old, Inclusive, With Moderate to Severe Malignant and/or Nonmalignant Pain Requiring Opioid Analgesics Medical Center of Central Georgia
Macon
478-743-7068

 
NCT01136733 E7080-G000-205 Kidney Cancer An Open-Label, Multicenter, Phase 1b/2 Study of E7080 Alone, and in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Renal Cell Carcinoma Following One Prior VEGF-Targeted Treatment Peachtree Hematology-Oncology Consultants, PC - Atlanta
Atlanta
678-298-3235


Peachtree Hematology-Oncology Consultants, PC - Fayetteville
Fayetteville

 
NCT01234402 13944
CP20-0903
I4Y-IE-JCDD
Breast Cancer An Open-Label, Multicenter, Randomized Phase 2 Study Evaluating the Safety and Efficacy of Ramucirumab (IMC-1121B) Drug Product or IMC-18F1 in Combination With Capecitabine or Capecitabine Monotherapy, in Unresectable, Locally Advanced or Metastatic Breas Emory University Hospital - Midtown
Atlanta
404-686-4411


Georgia Health Sciences University - CCRU
Augusta


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01347645 E7820-702
2011-001762-18
Colon/Rectal Cancer An Open-Label, Multicenter, Randomized Phase Ib/II Study of Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer
Atlanta
404-256-4777

 
NCT01662102 SPI-ZEV-12-302 Non-Hodgkin Lymphoma An Open-Label, Multicenter, Randomized Study in Previously Untreated Follicular Lymphoma Patients to Evaluate the Efficacy of Consolidation With Zevalin® Versus Maintenance Treatment With Rituximab After Initial Therapeutic Response to Rituximab Plus Chemotherapy Northeast Georgia Cancer Care, LLC - Athens Medical Oncology
Athens
706-353-2990

 
NCT01345214 ONO-7746POU003 Symptom Management An Open-label, Multiple-Dose Escalation Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced Thrombocytopenia Georgia Health Sciences University - Gynecologic Oncology
Augusta

 
NCT01223027 CTKI258A2302
EudraCT 2009-015459-25
Kidney Cancer An Open-label, Randomized, Multi-center, Phase III Study to Compare the Safety and Efficacy of TKI258 Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma After Failure of Anti-angiogenic (VEGF-targeted and mTOR Inhibitor) Therapies Northeast Georgia Cancer Care, LLC - Athens Medical Oncology
Athens
706-353-2990


Summit Cancer Care
Savannah
912-354-6187


Summit Cancer Care - Statesboro
Statesboro


Summit Cancer Care at Curtis and Elizabeth Anderson Cancer Institute
Savannah


Summit Cancer Care at the Nancy N. Lewis and J.C. Lewis Cancer & Research Pavilion
Savannah

 
NCT00931918 C05013 Non-Hodgkin Lymphoma An Open-Label, Randomized, Phase 2 Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
Lithonia



Marietta



Macon



Atlanta
404-256-4777



Decatur


Suburban Hematology-Oncology Associates, PC - Duluth
Duluth


Suburban Hematology-Oncology Associates, PC - Lawrenceville
Lawrenceville
678-533-1559


Suburban Hematology-Oncology Associates, PC - Snellville
Snellville


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01232556 B1931008
3129K5-3303
Non-Hodgkin Lymphoma An Open-Label, Randomized, Phase 3 Study Of Inotuzumab Ozogamicin Administered In Combination With Rituximab Compared To Defined Investigator's Choice Therapy In Subjects With Relapsed Or Refractory CD22-Positive Aggressive Non-Hodgkin Lymphoma Who Are Not Candidates For Intensive High-Dose Chemotherapy  
NCT01351415 MO22097 Lung Cancer An Open-label, Randomized, Phase IIIb Trial Evaluating the Efficacy and Safety of Standard of Care +/- Continuous Bevacizumab Treatment Beyond Progression of Disease (PD) in Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC) After First (1st)-Line Treatment With Bevacizumab Plus a Platinum Doublet-containing Chemotherapy  
NCT00884312 PX-171-010 Multiple Myeloma An Open-Label, Single Arm, Phase 2 Study of Carfilzomib Maintenance Therapy in Subjects Previously in Enrolled Carfilzomib Treatment Protocols  
NCT01585623 INT12497
U1111-1125-8930
Unknown Primary An Open-label, Two-treatment Crossover Pharmacokinetic Interaction Study of Repeated Doses of SAR302503 on Pharmacokinetics of a Single Dose Cocktail of Omeprazole, Metoprolol, and Midazolam Used as Probe Substrates for CYP2C19, CYP2D6 and CYP3A4 Activities, Respectively in Adult Patients With Refractory Solid Tumors  
NCT01286233 NSABP-NCIC-CTG-MA.32.F
NSABP-NCIC-CTG-MA.32.F
Breast Cancer Ancillary Study of Biobehavioral Mechanisms of Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin Hydrochloride Versus Placebo on NCIC-CTG-MA.32 Longstreet Cancer Center, PC
Gainesville


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


Phoebe Cancer Center at Phoebe Putney Memorial Hospital
Albany
800-572-1932


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa

 
NCT01360554 A7471009 Lung Cancer ARCHER 1009: A Randomized, Double-Blind Phase 3 Study Of PF-00299804, A Pan-Her Inhibitor, Vs. Erlotinib For The Treatment Of Advanced Non-Small Cell Lung Cancer Following Progression After, Or Intolerance To, At Least One Prior Chemotherapy Charles B. Eberhart Cancer Center at DeKalb Medical Center
Decatur
404-851-2340


Emory University Hospital - Midtown
Atlanta
404-686-4411


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Longstreet Cancer Center, PC
Gainesville


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


Phoebe Cancer Center at Phoebe Putney Memorial Hospital
Albany
800-572-1932


Suburban Hematology-Oncology Associates, PC - Duluth
Duluth


Suburban Hematology-Oncology Associates, PC - Lawrenceville
Lawrenceville
678-533-1559


Suburban Hematology-Oncology Associates, PC - Snellville
Snellville


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00899990 COG-AEWS07B1
AEWS07B1
Ewing Sarcoma Biological Specimen Collection and Banking From Patients With Ewing Sarcoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT00669422 PT-206 ChemoFx® PRO Study Ovarian Cancer ChemoFx® PRO - A Post-Market Data Collection Study Utilizing Physician Reported Outcomes  
NCT01120353 CCSS
U24CA055727
Multiple Primaries Childhood Cancer Survivor Study Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215

 
NCT01349621 CA156166 Gynecologic Cancers Clinical Evaluation of Polarized Light Assisted Colposcopy  
NCT00289146 IRB3 021-2005 Kidney Cancer Comparison of Immune Response Following Surgical Management of Renal Tumors  
NCT01081015 Connect™ CLL Leukemia Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Lithonia



Marietta



Macon



Atlanta
404-256-4777



Decatur


Lewis Hall Singletary Oncology Center at John D. Archbold Memorial Hospital
Thomasville


Northwest Georgia Oncology Centers, PC - Austell
Austell


Northwest Georgia Oncology Centers, PC - Carrollton
Carrollton


Northwest Georgia Oncology Centers, PC - Cartersville
Cartersville


Northwest Georgia Oncology Centers, PC - Douglasville
Douglasville


Northwest Georgia Oncology Centers, PC - Marietta
Marietta
770-281-5131


Peachtree Hematology-Oncology Consultants, PC - Atlanta
Atlanta
678-298-3235


Peachtree Hematology-Oncology Consultants, PC - Fayetteville
Fayetteville


Phoebe Cancer Center at Phoebe Putney Memorial Hospital
Albany
800-572-1932

 
NCT00665067 GCO 07-0548-00107
P01CA108671-05
MPD-RC 107
Myelodysplastic Syndromes (MDS) Correlative Biomarker Study for MPD-RC Treatment Studies in the Philadelphia Chromosome Negative MPD Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00628498 P2006-05 Symptom Management Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study (Under CFR 312.34) Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT00288444 174-2004
EU841-03
Prostate Cancer Defining the Interaction of Docetaxel and Lonafarnib in Patients With Advanced Malignancies  
NCT00048958 CALGB-8461 Leukemia Diagnostic Study of Cytogenetics in Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma  
NCT01705548 RAD2156-11
NCI-2012-01933
Unknown Primary Dose Escalation Trial of Fractionated Stereotactic Radiosurgery for Brain Metastasis Greater Than 3cm Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00932438 DEBIRI # 09.0034
UL2008.1
Colon/Rectal Cancer Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Concomitant Systemic Oxaliplatin, Fluorouracil and Leucovorin Chemotherapy, and Anti-Angiogenic Therapy Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01752114 1001-12 Unspecified Early Diagnosis of Pulmonary Nodules Using A Plasma Proteomic Classifier, Protocol Number 1001-12 Georgia Lung Associates - Austell
Austell
770-745-1404

 
NCT01095757 WCI1671-09 Non-Hodgkin Lymphoma Evaluation of Plerixafor (Mozobil ™, AMD3100) in Combination With Chemotherapy and G-CSF for CD34+ Cell Mobilization Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00229801 Renal Function/Brain Tumors Brain Cancer Evaluation of Renal Function in Children With Brain Tumors  
NCT01538628 AGX-11-001-US Prostate Cancer Evaluation of SpaceOAR™ System When Used to Create Space Between the Rectum and Prostate in Men Undergoing IG-IMRT for Localized Stage T1-T2 Prostate Cancer: A Randomized, Multicenter, Parallel Arm Controlled Clinical Study Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00228813 159-2004 Multiple Primaries Feasibility Study of Using G-CSF Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure Syndrome With Partially Mismatched Related Donors Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT00326417 383
BMT CTN 0301
5 U01 HL69294-05
FHCRC-2051.00
Hematologic Malignancies Fludarabine-based Conditioning for Allogeneic Marrow Transplantation From HLA-compatible Unrelated Donors in Severe Aplastic Anemia (BMT CTN #0301) Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT01188109 WCI1738-09 Pancreatic Cancer Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of Excision Repair Cross Complementation Gene 1(ERCC1)in Treatment Decision Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00228683 230-2005 Liver/ Hepatoblastoma Hepatoblastoma Biology Study and Tissue Bank  
NCT00209157 PC B305/04 Unspecified Hexvix Cystoscopy for Detection of Bladder Cancer  
NCT01141712 698
U01HL069294-06
BMT CTN 0803
Lymphoma High Dose Chemotherapy With Autologous Stem Cell Rescue for Aggressive B Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients (BMT CTN 0803) Northside Hospital Cancer Institute
Atlanta
404-303-3355


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00627393 557
HL072268
HL072291
HL072196
HL072248
HL072191
HL072305
HL072028
HL072072
HL072355
HL072283
HL072346
HL072331
HL072290
Symptom Management High Dose Granulocyte Transfusions for the Treatment of Infection in Neutropenia: The RING Study (Resolving Infection in Neutropenia With Granulocytes)  
NCT00352885 R01 MH071580
DATR A3-NSS
Symptom Management IL-2 Neuropsychiatric Symptoms: Mechanism and Prevention  
NCT00408005 CDR0000514500
COG-AALL0434
AALL0434
Leukemia Intensified Methotrexate, Nelarabine (Compound 506U78; IND #52611) and Augmented BFM Therapy for Children and Young Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) or T-cell Lymphoblastic Lymphoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT01587040 TED12414
U1111-1124-1403
2011-006140-78
Unknown Primary International, Multicenter, Open-label, Treatment-extension Study for Subjects Who Completed a Phase 1 or Phase 2 Parental Study to Continue Receiving Treatment With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen  
NCT01042379 097517 Breast Cancer I-SPY 2 Trial (Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2)  
NCT01288222 2010LSUC043
MT2010-06
P01CA111412
Leukemia KIR Genotyping for Unrelated Donor (URD) Selection Prior to Hematopoietic Cell Transplantation (HCT) for AML: Selecting a Favorable KIR Donor Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00897767 ECOG-E3903
E3903
Leukemia Laboratory Study of Diagnostic Sample Collection from Patients With Suspected Leukemia or Related Hematologic Disorders Being Considered for ECOG Leukemia Treatment Clinical Trials Georgia Health Sciences University Cancer Center
Augusta
706-721-5557

 
NCT01196936 08218
R01CA140245-01
Hodgkin Lymphoma Low-dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction: A Phase IIB Randomized Placebo-Controlled Trial  
NCT01523587 1200.125
2011-002380-24
Lung Cancer LUX-Lung 8: A Randomized, Open-label Phase III Trial of Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung as Second-line Therapy Following First-line Platinum-based Chemotherapy  
NCT00229814 Tectal Tumors MRS Unspecified Magnetic Resonance Spectroscopic Analysis of Pediatric Tectal Tumors: Insight Into Pathology and Behavior  
NCT01723423 10-PAF07150 Breast Cancer Mastectomy Reconstruction Outcomes Consortium (MROC) Study  
NCT00003861 CALGB-9862 Leukemia Molecular Monitoring Study in Adults With Previously Untreated Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia  
NCT01300585 Breast MRI Breast Cancer MRI Evaluation to Assess the Relationship Between the Areolar Margin and Underlying Breast Paryenchyma Attachments to the Dermis Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853

 
NCT01298570 LCCC 1029
10-2176
Colon/Rectal Cancer Multi-Center, Randomized, Placebo-Controlled Phase II Study of Regorafenib in Combination With FOLFIRI Versus Placebo With FOLFIRI as Second-Line Therapy in Patients With K-RAS or BRAF Mutant Metastatic Colorectal Cancer Emory University Hospital - Midtown
Atlanta
404-686-4411


Summit Cancer Care
Savannah
912-354-6187


Summit Cancer Care - Statesboro
Statesboro


Summit Cancer Care at Curtis and Elizabeth Anderson Cancer Institute
Savannah


Summit Cancer Care at the Nancy N. Lewis and J.C. Lewis Cancer & Research Pavilion
Savannah


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01260168 Exact Sciences 2010-A Colon/Rectal Cancer Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies Atlanta Gastroenterology Associates
Atlanta
770-612-8165

 
NCT01587300 N2004-05 Neuroblastoma N2004-05: Neuroblastoma Biology Study Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853

 
NCT00228696 199-96 Wilms Tumor National Wilm's Tumor Study Late Effects Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Georgia Health Sciences Medical Center - Pediatric Oncology
Augusta

 
NCT00528437 NYU 05-40 H12853
PBMTC ONC-032P
Brain Cancer NYU 05-40 PBMTC ONC-032P:High Dose Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue (ASCR) Followed by Continuation Therapy With 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01203020 WVU 11310 Leukemia Once Daily Intravenous Busulfex as Part of Reduced-toxicity Conditioning for Patients With Relapsed/Refractory Hodgkin's and Non-Hodgkin's Lymphomas Undergoing Allogeneic Hematopoietic Progenitor Cell Transplantation - A Multicenter Phase II Study Georgia Health Sciences University Cancer Center
Augusta
706-721-5557

 
NCT00634049 9766-CL-0103
WSA-CS-003
2006-005003-33
Symptom Management Open Label Study of Isavuconazole in the Treatment of Patients With Aspergillosis and Renal Impairment or of Patients With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi  
NCT01465347 DP100-202 Brain Cancer Open-label Phase 1/2 (Safety Lead-in) Study of Trans Sodium Crocetinate (TSC) With Concomitant Treatment of Fractionated Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM) Patients to Evaluate Safety and Efficacy Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01247922 OSI-774-206 Brain Cancer Open-label, Phase 2 Study of Single-agent Erlotinib for Patients With Pediatric Ependymoma Previously Treated With Oral Etoposide in Protocol OSI-774-205 Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01422265 130/070 Ovarian Cancer Patient Reported Symptoms in Ovarian Cancer Georgia Health Sciences University - Gynecologic Oncology
Augusta

 
NCT00966498 PBSCT for ST Multiple Primaries Peripheral Blood Stem Cell Transplantation in Children With High-Risk or Recurrent Solid Tumors  
NCT01160211 114299 Breast Cancer Ph III Trial to Compare Safety and Efficacy of Lapatinib Plus Trastuzumab Plus Aromatase Inhibitor (AI) vs. Trastuzumab Plus AI vs. Lapatinib Plus AI as 1st Line in Postmenopausal Subjects With Hormone Receptor+ HER2+ MBC Who Received Trastuzumab and Endo Suburban Hematology-Oncology Associates, PC - Duluth
Duluth


Suburban Hematology-Oncology Associates, PC - Lawrenceville
Lawrenceville
678-533-1559


Suburban Hematology-Oncology Associates, PC - Snellville
Snellville

 
NCT01075984 P05615
PO5520AM1
P05520
Symptom Management Pharmacokinetics and Safety of Solid Oral Posaconazole (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00461045 NPI-0052-101 Multiple Myeloma Phase 1 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma  
NCT01252628 PX-866-003 Multiple Primaries Phase 1/2 Study of PX-866 and Cetuximab Peachtree Hematology-Oncology Consultants, PC - Atlanta
Atlanta
678-298-3235


Peachtree Hematology-Oncology Consultants, PC - Fayetteville
Fayetteville

 
NCT00401778 1341-2004 Lung Cancer Phase 1b Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC) Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01416428 2011-001 Non-Hodgkin Lymphoma Phase 1b/2, Multicenter, Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00932451 A8081005 Lung Cancer Phase 2, Open-Label Single Arm Study Of The Efficacy And Safety Of PF-02341066 In Patients With Non-Small Cell Lung Cancer Harboring A Translocation Or Inversion Event Involving The Anaplastic Lymphoma Kinase (ALK) Gene  
NCT01439347 TTX404 Leukemia Phase 3 Study of Study to Evaluate Marqibo® in the Combination Chemotherapy in the Treatment of Subjects >or=60 Years Old With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01642251 NCI-2012-01985
ECOG-E2511
U10CA021115
CDR0000736704
E2511
Lung Cancer Phase I and Randomized Phase II Double Blind Clinical Trial of Cisplatin and Etoposide in Combination With Veliparib (ABT-888) or Placebo as Frontline Therapy for Extensive Stage Small Cell Lung Cancer Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01116336 WCI1549-08 Head and Neck Cancer Phase I Chemoprevention Study With Green Tea and Erlotinib in Patients With Premalignant Lesions of the Head and Neck Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01140607 POP6792
U1111-1116-5845
Unknown Primary Phase I Safety and Pharmacokinetic Study of XRP6258 (Cabazitaxel) In Advanced Solid Tumor Patients With Varying Degrees of Hepatic Impairment  
NCT01191216 MCC-16264
MCC-16264
8784
Multiple Primaries Phase I Study of 1-Methyl-D-Tryptophan and Docetaxel in Patients With Metastatic Solid Tumors Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01529138 WCI1939-10 Unknown Primary Phase I Study of Axitinib and Temsirolimus in Solid Tumors Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00989651 GOG-9923
GOG-9923
Ovarian Cancer Phase I Study of Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Georgia Health Sciences University - Gynecologic Oncology
Augusta

 
NCT01295502 GOG-9926
GOG-9926
Cervical Cancer Phase I Study of Cisplatin and Extended-Field Radiotherapy Followed by Paclitaxel and Carboplatin in Patients With Stage IB, IIA, IIB, IIIA, IIIB, or IVA Cervical Carcinoma Metastatic to the Para-Aortic Lymph Nodes Georgia Health Sciences University - Gynecologic Oncology
Augusta

 
NCT01218555 WCI1717-09 Multiple Primaries Phase I Study of Everolimus (RAD001) in Combination With Lenalidomide in Patients With Advanced Solid Malignancies Enriched for Renal Cell Carcinoma Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00295919 CDR0000459787
NANT-N2004-04
Neuroblastoma Phase I Study of Fenretinide (4-HPR, NSC 374551) Lym-X-Sorb™ (LXS) Oral Powder in Patients With Recurrent or Resistant Neuroblastoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01273090 COG-ADVL1112
ADVL1112
Multiple Primaries Phase I Study of Imetelstat Sodium in Children With Refractory or Recurrent Solid Tumors or Lymphoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01164163 COG-ADVL1011
ADVL1011
Multiple Primaries Phase I Study of Oral JAK Inhibitor INCB18424 in Pediatric Patients With Relapsed or Refractory Solid Tumors, Leukemias, or Myeloproliferative Neoplasms Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01446458 WCI1998-11 Pancreatic Cancer Phase I Study of Stereotactic Body Radiation Therapy and 5-Fluorouracil, Oxaliplatin and Irinotecan (FOLFIRINOX) in the Neoadjuvant Therapy of Pancreatic Cancer Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01403415 COG-ADVL1114
ADVL1114
Acute Lymphoblastic Leukemia Phase I Study of Temsirolimus and Intensive Re-Induction Therapy Comprising Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Children With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma  
NCT01294293 GOG-9925
GOG-9925
Ovarian Cancer Phase I Study of TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride in Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Georgia Health Sciences University - Gynecologic Oncology
Augusta

 
NCT01538095 COG-ADVL1115
ADVL1115
Unknown Primary Phase I Study of Trebananib in Children With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853

 
NCT01281150 PCI-09-084
09-084
8620
Multiple Primaries Phase I Study of Veliparib in Combination With Carboplatin and Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors  
NCT00535119 PCI-07-015
07-015
7967
Multiple Primaries Phase I Study of Veliparib, Carboplatin, and Paclitaxel in Patients With Advanced Solid Malignancies  
NCT01366144 UPCI-10-115
UPCI 10-115
8808
Multiple Primaries Phase I Study of Veliparib, Paclitaxel, and Carboplatin in Patients With Metastatic or Unresectable Solid Tumors and Hepatic or Renal Dysfunction  
NCT01208454 NANT-N2008-02
N2008-02
Neuroblastoma Phase I Study of Vorinostat in Combination With Isotretinoin in Patients With High-Risk Refractory or Recurrent Neuroblastoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01218542 WBRT-RA-2010 Metastases Phase I Study of Whole Brain Radiation Therapy With Simultaneous Boost to Gross Metastatic Tumor Volume Using RapidArc Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01434459 WCI1907-10 Liver Cancer Phase I Trial of Gemcitabine With TheraSphere® (Yttrium-90) in Patients With Hepatic Tumors of Pancreatobiliary Origin Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01395407 SRS-Cavity-01 Metastases Phase I Trial of Stereotactic Radiosurgery Following Surgical Resection of Intra-axial Brain Metastases Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01381692 ECOG-E1A10
E1A10
Non-Hodgkin Lymphoma Phase I/II Randomized Study of Bortezomib, Rituximab, and Dexamethasone With Versus Without Temsirolimus in Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell, Follicular, Marginal Zone, or Small Lymphocytic Lymphoma Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00295932 MSKCC-05103 Non-Hodgkin Lymphoma Phase I/II Randomized Study of Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Patients With Relapsed or Refractory Indolent B-Cell Lymphoproliferative Disorders or Mantle Cell Lymphoma  
NCT00869401 NCCTG-N0877
N0877
Brain Cancer Phase I/II Randomized Study of Dasatinib Versus Placebo and Chemoradiotherapy With Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449

 
NCT01064648 SWOG-S0905
S0905
Mesothelioma Phase I/II Randomized Study of Pemetrexed Disodium and Cisplatin With Versus Without Cediranib Maleate in Patients With Malignant Pleural Mesothelioma Longstreet Cancer Center, PC
Gainesville


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa

 
NCT01034631 HOG GU09-145 Kidney Cancer Phase I/II Study of BNC105P in Combination With Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors Dublin Hematology and Oncology Care
Dublin
478-275-1111


Northeast Georgia Cancer Care, LLC - Athens Medical Oncology
Athens
706-353-2990

 
NCT00939770 COG-ADVL0912
ADVL0912
Multiple Primaries Phase I/II Study of Crizotinib in Children With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01601535 N2009-03 Neuroblastoma Phase I/II Study of MLN8237 in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853

 
NCT01388647 ACORN ALSSNBC1006 Breast Cancer Phase I/II Study of Neoadjuvant Carboplatin, Eribulin Mesylate and Trastuzumab (ECH) for Operable HER2 Positive Breast Cancer Northeast Georgia Cancer Care, LLC - Athens Medical Oncology
Athens
706-353-2990

 
NCT01105312 NCCTG-N093B
N093B
Breast Cancer Phase I/II Study of Panobinostat and Letrozole in Patients With Metastatic Breast Cancer (The Phase I portion of this study closed and the Phase II portion of the study opened as per NCCTG Addendum 6, effective January 23, 2012.) John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449

 
NCT00400374 0405-2006 Head and Neck Cancer Phase I/II Study of Secondary Primary Tumor Prevention With Epidermal Growth Factor Receptor (EGFR), Tyrosine Kinase Inhibitor Erlotinib (OSI-774, Tarceva™ ), and Cyclooxygenase-2 (COX-2) Inhibitor (Celecoxib) in Early Stage (Stage I/II) Squamous Cell Car Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00546793 IM-T-hA20-08 Leukemia Phase I/II Study of Subcutaneously Administered Veltuzumab (hA20) in Patients With CD20+ Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia St. Joseph's/Candler Hospital
Savannah
(912) 819-6204

 
NCT00416455 ACRIN-6671
GOG-0233
Cervical Cancer Phase I/II Study of the Utility of Preoperative Fludeoxyglucose F 18 Positron Emission Tomography/CT Scanning and Ferumoxtran-10 MRI Scanning Prior to Primary Chemoradiotherapy in Detecting Retroperitoneal Lymph Node Metastasis in Patients With Locoreg Georgia Health Sciences University - CCRU
Augusta

 
NCT01189266 COG-ACNS0927
ACNS0927
Brain Cancer Phase I/II Study of Vorinostat and Local Radiotherapy Followed By Maintenance Vorinostat in Pediatric Patients With Newly Diagnosed Intrinsic Pontine Gliomas Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT00634634 040706
NJ 1107
0220070284
Breast Cancer Phase I/II Trial of Letrozole (Femara) and Sorafenib (Nexavar) in Postmenopausal Women With Hormone-Receptor Positive Locally Advanced or Metastatic Breast Cancer Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01194908 WCI1696-09 Breast Cancer Phase I/II Trial of Tamoxifen Following Epigenetic Regeneration of Estrogen Receptor Using Decitabine and LBH 589 in Patients With Triple Negative Metastatic Breast Cancer Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00856830 F080929010
UAB 0818
Lung Cancer Phase I/IIa Study of the Novel Combination of Bendamustine With Irinotecan Followed by Etoposide/Carboplatin in Chemonaive Patients With Extensive Stage Small Cell Lung Cancer
Lithonia



Marietta



Macon



Atlanta
404-256-4777



Decatur

 
NCT01490749 WCI1871-10 Head and Neck Cancer Phase I/IIB Study of Induction Chemotherapy With XELOX, Followed by Radiation Therapy and Dose Escalation of RAD001 in Patients With Esophageal Cancer Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01498588 WCI1937-10 Breast Cancer Phase II Neoadjuvant Trial of Eribulin Followed by Dose Dense Doxorubicin and Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00873093 COG-AALL07P1
AALL07P1
Leukemia Phase II Pilot Study of Bortezomib in Combination With Intensive Reinduction Chemotherapy in Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT00553202 COG-AAML05P1
AAML05P1
Acute Myelogenous Leukemia Phase II Pilot Study of Killer Immunoglobulin-Like Receptor-Incompatible Unrelated Donor Hematopoietic Cell Transplantation in Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3 Internal Tandem Duplication Allelic Ratio (High- Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01124695 ECOG-E3108
E3108
Breast Cancer Phase II Prospective Study of CYP2D6 Activity in Patients With Metastatic or Recurrent Breast Cancer Treated With Tamoxifen Citrate Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph's/Candler
Savannah
912-819-6204

 
NCT01220583 RTOG-1008
RTOG-1008
Oral Cancer Phase II Randomized Study of Adjuvant Radiotherapy With Versus Without Concurrent Chemotherapy in Patients With Resected High-Risk Malignant Salivary Gland Tumors Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01522976 SWOG-S1117
S1117
Myelodysplastic Syndromes (MDS) Phase II Randomized Study of Azacitidine With Versus Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia  
NCT01305213 GOG-0186I
GOG-0186I
Ovarian Cancer Phase II Randomized Study of Bevacizumab With Versus Without Fosbretabulin Tromethamine in Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Carcinoma Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT01251861 ECOG-E2809
E2809
Prostate Cancer Phase II Randomized Study of Bicalutamide With Versus Without Akt Inhibitor MK2206 in Patients With Prostate Cancer and Rising PSA at High-Risk of Progression After Primary Therapy Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01280058 OSU-10045
OSU-10045
8601
Pancreatic Cancer Phase II Randomized Study of Carboplatin and Paclitaxel With Versus Without Wild-Type Reovirus (Reolysin®) as First-Line Treatment in Patients With Recurrent or Metastatic Pancreatic Cancer Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00976573 NCCTG-N0879
N0879
Melanoma Phase II Randomized Study of Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Patients With Metastatic Malignant Melanoma John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449

 
NCT00777491 RTOG-0712
RTOG 0712
Bladder Cancer Phase II Randomized Study of Chemoradiotherapy Comprising Fluorouracil, Cisplatin, and Radiotherapy Versus Gemcitabine Hydrochloride and Radiotherapy Followed By Selective Bladder Preservation and Adjuvant Chemotherapy Comprising Gemcitabine Hydrochloride Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00661193 SWOG-S0709
S0709
Lung Cancer Phase II Randomized Study of Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer Pearlman Comprehensive Cancer Center at South Georgia Medical Center
Valdosta
229-259-4628

 
NCT01434290 RTOG-0938
RTOG 0938
Prostate Cancer Phase II Randomized Study of Hypofractionated Radiotherapy in Patients With Favorable-Risk Prostate Cancer Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00857545 GOG-0255
GOG-0255
Ovarian Cancer Phase II Randomized Study of Immunological Adjuvant OPT-821 With Versus Without Polyvalent Antigen-KLH Conjugate Vaccine in Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer in Second or Third Complete Clinical Remission  
NCT01553149 COG-ACNS1022
ACNS1022
Brain Cancer Phase II Randomized Study of Lenalidomide in Pediatric Patients With Recurrent, Refractory, or Progressive Juvenile Pilocytic Astrocytoma or Optic Pathway Glioma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853

 
NCT01533181 MCC-16628
MCC 16628
8873
Lung Cancer Phase II Randomized Study of Linsitinib Versus Topotecan Hydrochloride in Patients With Relapsed Small Cell Lung Cancer  
NCT01009918 SCUSF-0806
SCUSF 0806
HLMCC-0806
Breast Cancer Phase II Randomized Study of Lisinopril or Carvedilol Phosphate Extended-Release in Reducing Cardiotoxicity in Women With HER2-Positive Breast Cancer Receiving Adjuvant or Neoadjuvant Trastuzumab Georgia Health Sciences University
Augusta


Longstreet Cancer Center, PC
Gainesville


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


Phoebe Cancer Center at Phoebe Putney Memorial Hospital
Albany
800-572-1932


St. Joseph's/Candler Hospital
Savannah
(912) 819-6204


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa

 
NCT01042522 GOG-0264
GOG-0264
Ovarian Cancer Phase II Randomized Study of Paclitaxel and Carboplatin Versus Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Patients With Advanced or Recurrent Sex Cord-Stromal Tumors of the Ovary Central Georgia Gynecologic Oncology
Macon
476-633-6090


Medical Center of Central Georgia
Macon
478-743-7068

 
NCT01468909 GOG-0186J
GOG-0186J
Gynecologic Cancers Phase II Randomized Study of Paclitaxel With or Without Pazopanib Hydrochloride in Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma Central Georgia Gynecologic Oncology
Macon
476-633-6090


Medical Center of Central Georgia
Macon
478-743-7068

 
NCT00492778 GOG-0238
GOG-0238
Endometrial Cancer Phase II Randomized Study of Pelvic Radiotherapy With Versus Without Cisplatin in Patients With Recurrent Endometrial Cancer Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT01055197 RTOG-0937
RTOG-0937
Lung Cancer Phase II Randomized Study of Prophylactic Cranial Irradiation With Versus Without Consolidative Extracranial Radiotherapy in Patients With Extensive Stage Small Cell Lung Cancer Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01013961 ECOG-E1908
E1908
Leukemia Phase II Randomized Study of Rituximab and Alemtuzumab in Elderly Patients With Progressive Chronic Lymphocytic Leukemia Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph's/Candler
Savannah
912-819-6204

 
NCT01658943 SWOG-S1115
S1115
Pancreatic Cancer Phase II Randomized Study of Selumetinib and Akt Inhibitor MK2206 Versus mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Previously Treated Patients With Metastatic Pancreatic Cancer Pearlman Comprehensive Cancer Center at South Georgia Medical Center
Valdosta
229-259-4628

 
  MCC-VICCMEL1120
VICCMEL1120
8867
Melanoma Phase II Randomized Study of Selumetinib With Versus Without Akt Inhibitor MK2206 in Patients With BRAF V600E Mutant Stage III or IV Melanoma Who Failed Prior Therapy With Vemurafenib or Dabrafenib  
NCT01164228 ECOG-E1808
E1808
Kidney Cancer Phase II Randomized Study of Sunitinib Malate With Versus Without Gemcitabine Hydrochloride in Patients With Advanced Unresectable Renal Cell Carcinoma With Sarcomatoid Features Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01217437 COG-ACNS0821
ACNS0821
Brain Cancer Phase II Randomized Study of Temozolomide and Irinotecan Hydrochloride With Versus Without Bevacizumab in Pediatric Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01143402 MSKCC-10053
10-053
8443
Melanoma Phase II Randomized Study of Temozolomide Versus MEK Inhibitor AZD6244 in Patients With Metastatic Uveal Melanoma Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01105130 CCCWFU-98110
WFU-08-08-09
CCCWFU 98110
Prostate Cancer Phase II Randomized Study of the Effect of an L-Arginine/Korean Ginseng/ Gingko Biloba/Damiana-Based Supplement With or Without Phosphodiesterase-5 Inhibitors on Erectile Function and Quality of Life in Prostate Cancer Survivors Previously Treated With Radiotherapy Georgia Health Sciences University
Augusta

 
NCT01349972 JHOC-J1101
J1101
8972
Leukemia Phase II Randomized Study of Timed-Sequential Therapy Comprising Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride Versus Cytarabine and Daunorubicin Hydrochloride in Patients With Newly Diagnosed Acute Myeloid Leukemia Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT01222715 COG-ARST0921
ARST0921
Rhabdomyosarcoma Phase II Randomized Study of Vinorelbine Ditartrate and Cyclophosphamide in Combination With Bevacizumab Versus Temsirolimus in Patients With Recurrent or Refractory Rhabdomyosarcoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01622868 RTOG-1119
RTOG-1119
Breast Cancer Phase II Randomized Study of Whole-Brain Radiotherapy With Versus Without Lapatinib Ditosylate in Patients With Brain Metastasis From HER2-Positive Breast Cancer Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393

 
NCT00700882 ECOG-E2607
E2607
Melanoma Phase II Study of Dasatinib in Patients With Unresectable Locally Advanced or Metastatic Mucosal, Acral, or Vulvovaginal Melanoma Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01121120 TXA127-2009-001 Non-Hodgkin Lymphoma Phase II Study Evaluating the Safety and Efficacy of TXA127 in the Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant in Patients With Hodgkin Lymphoma, Non-Hodgkin Lymphoma or Multiple Myeloma Undergoing Limited Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00031590 CHP-693
CHP-IRB-2001-12-2301
NCI-V01-1680
Brain Cancer Phase II Study of Adjuvant Reduced-Dose Craniospinal Radiotherapy With Vincristine Followed By Maintenance Chemotherapy in Children With Newly Diagnosed Standard-Risk Posterior Fossa Primitive Neuroectodermal Tumor or Medulloblastoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01260701 SWOG-S1005
S1005
Colon/Rectal Cancer Phase II Study of Akt Inhibitor MK2206 as Second-Line Therapy in Patients With Advanced Gastric or Gastroesophageal Junction Cancer Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT01154816 COG-ADVL0921
ADVL0921
Multiple Primaries Phase II Study of Aurora A Kinase Inhibitor MLN8237 in Pediatric Patients With Recurrent or Refractory Solid Tumors or Leukemia Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01216683 ECOG-E2408
E2408
Non-Hodgkin Lymphoma Phase II Study of Bendamustine Hydrochloride and Rituximab With Versus Without Bortezomib Followed by Rituximab With Versus Without Lenalidomide in Patients With High-Risk Stage II-IV Follicular Lymphoma Georgia Health Sciences University Cancer Center
Augusta
706-721-5557

 
NCT00703664 MCC-15428
MCC-15428
8064
Non-Hodgkin Lymphoma Phase II Study of Bortezomib and Vorinostat in Patients With Recurrent Mantle Cell Lymphoma or Recurrent and/or Refractory Diffuse Large B-Cell Lymphoma Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00316888 ECOG-E3205
E3205
Colon/Rectal Cancer Phase II Study of Cetuximab, Cisplatin, Fluorouracil, and Radiotherapy in Immunocompetent Patients With Stage I-IIIB Invasive Anal Carcinoma (Arm I Closed to Accrual as of 11/3/2008) Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01602666 COG-ACNS1123
ACNS1123
Brain Cancer Phase II Study of Chemotherapy Followed by Response-Based Radiotherapy in Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853

 
NCT00558519 CALGB-10403
CALGB 10403
ECOG C10403
SWOG C10403
Leukemia Phase II Study of Combination Chemotherapy in Adolescents and Young Adults With Newly Diagnosed Acute Lymphoblastic Leukemia  
NCT00335556 COG-AREN0321
AREN0321
Kidney Cancer Phase II Study of Combination Chemotherapy, Radiotherapy, and/or Surgery in Patients With High-Risk Renal Tumors Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT00792948 SWOG-S0805
S0805
Leukemia Phase II Study of Cytarabine, Methotrexate, Cyclophosphamide, Dexamethasone, Doxorubicin Hydrochloride, Vincristine (HCVAD) and Dasatinib With or Without Allogeneic Stem Cell Transplantation in Patients With Philadelphia Chromosome- and/or BCR/ABL-Positive Acute Lymphoblastic Leukemia Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01266460 GOG-0265
GOG-0265
GOG-0265
Cervical Cancer Phase II Study of Live-Attenuated Listeria Monocytogenes Cancer Vaccine ADXS11-001 in Patients With Persistent or Recurrent Squamous Cell or Non-Squamous Cell Carcinoma of the Cervix Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT00733746 ACOSOG-Z5041
Z5041
Pancreatic Cancer Phase II Study of Neoadjuvant and Adjuvant Gemcitabine Hydrochloride and Erlotinib Hydrochloride in Patients With Resectable Adenocarcinoma of the Pancreas Undergoing Pancreatectomy Charles B. Eberhart Cancer Center at DeKalb Medical Center
Decatur
404-851-2340


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT00895622 RTOG-0539
RTOG 0539
Brain Cancer Phase II Study of Observation or Radiotherapy in Patients With Grade I, II, or III Meningioma Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00006227 GOG-0187 Ovarian Cancer Phase II Study of Paclitaxel in Patients With Ovarian Stromal Cancer Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT01359592 SWOG-S1001
S1001
Non-Hodgkin Lymphoma Phase II Study of PET-Directed Therapy in Patients With Limited-Stage Diffuse Large B-Cell Lymphoma Charles B. Eberhart Cancer Center at DeKalb Medical Center
Decatur
404-851-2340


Gwinnett Medical Center
Lawrenceville
404-851-2340


Harbin Clinic Cancer Center
Rome
404-851-2340


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Saint Joseph's Hospital of Atlanta
Atlanta
678-843-7119


Southern Regional Medical Center
Riverdale
770-997-1975


WellStar Cobb Hospital
Austell
770-793-5980


Wellstar Kennestone Hospital
Marietta
770-793-5980

 
NCT01027000 CALGB-100701
CALGB 100701
Leukemia Phase II Study of Reduced-Intensity Allogeneic Stem Cell Transplantation in Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT01132807 CALGB-50604
CALGB-50604
Hodgkin Lymphoma Phase II Study of Response-Adapted Chemotherapy Based on Positron Emission Tomography in Patients With Non-Bulky Stage I or II Hodgkin Lymphoma Georgia Health Sciences University Cancer Center
Augusta
706-721-5557

 
NCT00822120 SWOG-S0816
S0816
Hodgkin Lymphoma Phase II Study of Response-Adapted Therapy Using Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy Comprising ABVD With Versus Without Combination Chemotherapy Comprising Standard or Escalated BEACOPP in Patients with Stage III-IV Hodgkin L Georgia Health Sciences University Cancer Center
Augusta
706-721-5557

 
NCT00551525 RTOG-0622
RTOG 0622
Prostate Cancer Phase II Study of Samarium Sm 153 Lexidronam Pentasodium Followed by Intensity-Modulated Radiation Therapy or Three-Dimensional Conformal Radiation Therapy in Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449

 
NCT00521118 GOG-0242
GOG-0242
Gynecologic Cancers Phase II Study of Second Curettage in Patients With Persistent, Low-Risk, Non-Metastatic Gestational Trophoblastic Neoplasia Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT00981656 RTOG-0926
RTOG-0926
Bladder Cancer Phase II Study of Selective Bladder-Preserving Radiotherapy and Concurrent Radiosensitizing Chemotherapy in Patients With Stage I Bladder Cancer Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01502410 COG-ADVL1121
ADVL1121
Thyroid Cancer Phase II Study of Sorafenib Tosylate in Children and Young Adults With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Hepatocellular Carcinoma, or Papillary Thyroid Carcinoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853

 
NCT00375219 CHEMGENEX-CGX-635-CML-202
MDA-2006-0192
EUDRACT-2006-000176-32
OLMMC-06-033
Leukemia Phase II Study of Subcutaneous Homoharringtonine in Patients With Imatinib Mesylate-Resistant, Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia With the T315I BCR-ABL Gene Mutation  
NCT01462695 COG-ACNS1021
ACNS1021
Brain Cancer Phase II Study of Sunitinib Malate in Pediatric and Young Adult Patients With Recurrent, Refractory, or Progressive High-Grade Glioma or Ependymoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853

 
NCT01010126 MAYO-MC0845
MC0845
8233
Lung Cancer Phase II Study of Temsirolimus and Bevacizumab in Patients With Locally Advanced, Recurrent, Metastatic, or Progressive Endometrial Cancer, Ovarian Epithelial Cancer, Hepatocellular Carcinoma, Islet Cell Cancer, or Carcinoid Tumor  
NCT01196429 GOG-0268
GOG-0268
Ovarian Cancer Phase II Study of Temsirolimus in Combination With Carboplatin and Paclitaxel Followed By Temsirolimus Consolidation as First-Line Therapy in Patients With Newly Diagnosed Stage III-IV Clear Cell Carcinoma of the Ovary Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT00450411 RTOG-0526 Prostate Cancer Phase II Study of Transperineal Ultrasound-Guided Iodine I 125 or Palladium Pd 103 Brachytherapy in Patients With Locally Recurrent Adenocarcinoma of the Prostate Previously Treated With External-Beam Radiotherapy Northside Hospital Cancer Institute
Atlanta
404-303-3355


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01266447 GOG-0127W
GOG-0127W_2010-12-14
Cervical Cancer Phase II Study of Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Patients With Persistent or Recurrent Squamous Cell or Non-Squamous Cell Carcinoma of the Cervix Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT01161628 NSH 893 Symptom Management Phase II Trial Evaluating the Safety and Efficacy of Rituximab as Primary Treatment for Extensive Chronic Graft Versus Host Disease Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT01401959 SCRI BRE 186 Breast Cancer Phase II Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy Longstreet Cancer Center, PC
Gainesville


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa

 
NCT01272141 WCI1711-09 Breast Cancer Phase II Trial of Lapatinib in Combination With Everolimus in Triple Negative Metastatic or Locally Advanced Breast Cancer Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00832338 WCI1505-08 Breast Cancer Phase II Trial of Pre-Operative Docetaxel-Cytoxan (TC) in Patients With Hormone Receptor-Positive Cancers With Recurrence Scores = 25 Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00906282 SCRI LUN 186 Lung Cancer Phase II Trial of Preoperative Pemetrexed and Carboplatin in Patients With Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer Longstreet Cancer Center, PC
Gainesville


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa

 
NCT01326312 G200705 Prostate Cancer Phase II, Open Label, Dose Finding Study of the Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer Compared to a Luteinizing Hormone Releasing Hormone Agonist  
NCT01393119 G200710 Prostate Cancer Phase II, Open-label, Loading and Maintenance Dose Finding Study of GTx-758 in Men With Prostate Cancer  
NCT00922974 RTOG-0631
RTOG 0631
Metastases Phase II/III Randomized Study of Image-Guided Radiosurgery or Stereotactic Body Radiotherapy in Patients With Localized Spine Metastasis Northside Hospital Cancer Institute
Atlanta
404-303-3355


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01515787 NCCTG-N1048
N1048
Colon/Rectal Cancer Phase II/III Randomized Study of Neoadjuvant FOLFOX Therapy Comprising Oxaliplatin, Leucovorin Calcium, and Fluorouracil Versus Chemoradiation Comprising Fluorouracil or Capecitabine and Radiation Therapy in Patients With Locally Advanced Rectal Cancer Undergoing Low-Anterior Resection With Total Mesorectal Excision John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449

 
NCT00626990 EORTC-26053
CAN-NCIC-CEC1
CEC1
RTOG-0834
EORTC-22054
EUDRACT-2006-001533-17
SPRI-EORTC-26053
MERCK-EORTC-26053
MRC-BR14
COGNO-EORTC-26053
Brain Cancer Phase III Randomized Study of Radiotherapy With or Without Concurrent and/or Adjuvant Temozolomide in Patients With Non-1p/19q Deleted Anaplastic Glioma Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00377156 NCCTG-N0574
N0574
ACOSOG-N0574
Metastases Phase III Randomized Study of Stereotactic Radiosurgery With Versus Without Whole-Brain Radiotherapy in Patients With Cerebral Metastases Atlanta Cancer Care - Alpharetta
Alpharetta
404-851-2359


Atlanta Cancer Care - Conyers
Conyers


Atlanta Cancer Care - Cumming
Cumming


Atlanta Cancer Care - Decatur
Decatur


Atlanta Cancer Care - Perimeter
Atlanta
404-851-2359


Atlanta Cancer Care - Stockbridge
Lake Spivey


Charles B. Eberhart Cancer Center at DeKalb Medical Center
Decatur
404-851-2340


Hamilton Regional Cancer Institute
Dalton


Harbin Clinic Cancer Center
Rome
404-851-2340


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Longstreet Cancer Center, PC
Gainesville


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853


Saint Joseph's Hospital of Atlanta
Atlanta
678-843-7119


Southern Regional Medical Center
Riverdale
770-997-1975


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa


WellStar Cobb Hospital
Austell
770-793-5980

 
NCT01241500 04-21 Myelodysplastic Syndromes (MDS) Phase III MultiCenter Randomized Controlled Study to Assess Efficacy and Safety of ON 01910.Na 72-Hr Continuous IV Infusion in MDS Patients With Excess Blasts Relapsing After or Refractory to or Intolerant to Azacitidine or Decitabine Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01190930 COG-AALL0932
AALL0932
Acute Lymphoblastic Leukemia Phase III Partially Randomized Study of Risk-Adapted Chemotherapy in Pediatric Patients With Newly Diagnosed Standard-Risk B-Precursor Acute Lymphoblastic Leukemia Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451


Georgia Health Sciences Medical Center - Pediatric Oncology
Augusta

 
NCT00557193 COG-AALL0631
AALL0631
Acute Lymphoblastic Leukemia Phase III Partially Randomized Study of Risk-Directed Therapy Comprising a Modified P9407 Chemotherapy Backbone With or Without Lestaurtinib in Infants With Newly Diagnosed Acute Lymphoblastic Leukemia Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT01096368 COG-ACNS0831
ACNS0831
Brain Cancer Phase III Randomized Study of Maintenance Chemotherapy Comprising Vincristine Sulfate, Cisplatin, Etoposide, and Cyclophosphamide Versus Observation in Pediatric Patients With Newly Diagnosed Ependymoma Following Induction Chemotherapy and Post-Operati Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01231906 COG-AEWS1031
AEWS1031
Brain Cancer Phase III Randomized Study of Adding Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide to Standard Chemotherapy in Patients With Non-Metastatic Extracranial Ewing Sarcoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451


Georgia Health Sciences Medical Center - Pediatric Oncology
Augusta

 
NCT01503632 COG-ACCL1033
ACCL1033
Acute Lymphoblastic Leukemia Phase III Randomized Study of Adherence to Maintenance Mercaptopurine Therapy in Pediatric Patients With Acute Lymphoblastic Leukemia in First Remission Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853

 
NCT01011478 NSABP-P-5
NSABP P-5
Colon/Rectal Cancer Phase III Randomized Study of Adjuvant Rosuvastatin in Patients With Resected Stage I or II Colon Cancer Atlanta Cancer Care - Alpharetta
Alpharetta
404-851-2359


Atlanta Cancer Care - Conyers
Conyers


Atlanta Cancer Care - Cumming
Cumming


Atlanta Cancer Care - Decatur
Decatur


Atlanta Cancer Care - Perimeter
Atlanta
404-851-2359


Atlanta Cancer Care - Stockbridge
Lake Spivey


Charles B. Eberhart Cancer Center at DeKalb Medical Center
Decatur
404-851-2340


Georgia Health Sciences University
Augusta


Gwinnett Medical Center
Lawrenceville
404-851-2340


Hamilton Regional Cancer Institute
Dalton


Harbin Clinic Cancer Center
Rome
404-851-2340


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Phoebe Cancer Center at Phoebe Putney Memorial Hospital
Albany
800-572-1932


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853


Saint Joseph's Hospital of Atlanta
Atlanta
678-843-7119


WellStar Cobb Hospital
Austell
770-793-5980


Wellstar Kennestone Hospital
Marietta
770-793-5980

 
NCT00108745 GOG-0212 Ovarian Cancer Phase III Randomized Study of Paclitaxel Versus Polyglutamate Paclitaxel as Consolidation/Maintenance Therapy Versus No Further Anticancer Therapy Until Disease Progression in Patients With Stage III or IV Ovarian Epithelial or Primary Peritoneal Cance Central Georgia Gynecologic Oncology
Macon
476-633-6090


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Medical Center of Central Georgia
Macon
478-743-7068


Southeastern Gynecologic Oncology, LLC
Gainesville

 
NCT00567580 RTOG-0534
RTOG 0534
Prostate Cancer Phase III Randomized Study of Prostate Bed Radiotherapy (PBRT) Alone Versus Short Term Androgen Deprivation Comprising Antiandrogen and Luteinizing Hormone-Releasing Hormone Agonist Therapy and Pelvic Lymph Node Radiotherapy With Versus Without PBRT i Atlanta Cancer Care - Alpharetta
Alpharetta
404-851-2359


Atlanta Cancer Care - Conyers
Conyers


Atlanta Cancer Care - Cumming
Cumming


Atlanta Cancer Care - Decatur
Decatur


Atlanta Cancer Care - Perimeter
Atlanta
404-851-2359


Atlanta Cancer Care - Stockbridge
Lake Spivey


Charles B. Eberhart Cancer Center at DeKalb Medical Center
Decatur
404-851-2340


Emory University Hospital - Midtown
Atlanta
404-686-4411


Gwinnett Medical Center
Lawrenceville
404-851-2340


Hamilton Regional Cancer Institute
Dalton


Harbin Clinic Cancer Center
Rome
404-851-2340


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Longstreet Cancer Center, PC
Gainesville


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393


Northside Hospital Cancer Institute
Atlanta
404-303-3355



Gainesville


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853


Saint Joseph's Hospital of Atlanta
Atlanta
678-843-7119


Southern Regional Medical Center
Riverdale
770-997-1975


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa


WellStar Cobb Hospital
Austell
770-793-5980


Wellstar Kennestone Hospital
Marietta
770-793-5980


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00354835 COG-ARST0531
ARST0531
Bone and Soft Tissue (including Sarcoma) Phase III Randomized Study of Vincristine, Dactinomycin, and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine and Irinotecan Hydrochloride in Combination With Radiotherapy in Patients With Newly Diagnosed, Intermediate-Risk Rhabdomyosarcoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT01349322 RTOG-1005
RTOG-1005
Breast Cancer Phase III Randomized Study of Accelerated Hypofractionated Whole-Breast Irradiation and Concurrent Boost Versus Standard Whole-Breast Irradiation and Sequential Boost in Patients With Early-Stage Breast Cancer After Lumpectomy Northside Hospital Cancer Institute
Atlanta
404-303-3355


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853


St. Joseph's/Candler Hospital
Savannah
(912) 819-6204

 
NCT00942357 GOG-0258
GOG-0258
Endometrial Cancer Phase III Randomized Study of Adjuvant Chemoradiotherapy Comprising Cisplatin and Tumor Volume-Directed Radiotherapy Followed by Carboplatin and Paclitaxel Versus Carboplatin and Paclitaxel Alone in Patients With Stage I-IVA Endometrial Carcinoma Central Georgia Gynecologic Oncology
Macon
476-633-6090


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Medical Center of Central Georgia
Macon
478-743-7068


Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT00565851 GOG-0213
GOG-0213
Ovarian Cancer Phase III Randomized Study of Adjuvant Chemotherapy Comprising Carboplatin and Paclitaxel With Versus Without Bevacizumab and/or Secondary Cytoreduction Surgery in Patients With Platinum-Sensitive Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Georgia Health Sciences University - Gynecologic Oncology
Augusta


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Southeastern Gynecologic Oncology, LLC
Gainesville

 
NCT00324805 ECOG-E1505
E1505
SWOG-E1505
CALGB-E1505
CAN-NCIC-E1505
NCCTG-E1505
Lung Cancer Phase III Randomized Study of Adjuvant Chemotherapy With or Without Bevacizumab in Patients With Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer Atlanta Cancer Care - Alpharetta
Alpharetta
404-851-2359


Atlanta Cancer Care - Conyers
Conyers


Atlanta Cancer Care - Cumming
Cumming


Atlanta Cancer Care - Decatur
Decatur


Atlanta Cancer Care - Perimeter
Atlanta
404-851-2359


Atlanta Cancer Care - Stockbridge
Lake Spivey


Augusta Oncology Associates - St. Sebastian Way
Augusta
706-821-2944


Charles B. Eberhart Cancer Center at DeKalb Medical Center
Decatur
404-851-2340


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Emory University Hospital - Midtown
Atlanta
404-686-4411


Georgia Health Sciences University Cancer Center
Augusta
706-721-5557


Gwinnett Medical Center
Lawrenceville
404-851-2340


Hamilton Regional Cancer Institute
Dalton


Harbin Clinic Cancer Center
Rome
404-851-2340


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Longstreet Cancer Center, PC
Gainesville


Medical Center of Central Georgia
Macon
478-743-7068


Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph's/Candler
Savannah
912-819-6204


Northeast Georgia Cancer Care, LLC - Athens Medical Oncology
Athens
706-353-2990


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


Phoebe Cancer Center at Phoebe Putney Memorial Hospital
Albany
800-572-1932


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853


Saint Joseph's Hospital of Atlanta
Atlanta
678-843-7119


Southern Regional Medical Center
Riverdale
770-997-1975


St. Joseph's/Candler Hospital
Savannah
(912) 819-6204


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa


Veterans Affairs Medical Center - Atlanta
Decatur
404-728-7680


WellStar Cobb Hospital
Austell
770-793-5980


Wellstar Kennestone Hospital
Marietta
770-793-5980


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01275677 NSABP-B-47 Breast Cancer Phase III Randomized Study of Adjuvant Chemotherapy With Versus Without Trastuzumab in Women With Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer Atlanta Cancer Care - Alpharetta
Alpharetta
404-851-2359


Atlanta Cancer Care - Conyers
Conyers


Atlanta Cancer Care - Cumming
Cumming


Atlanta Cancer Care - Decatur
Decatur


Atlanta Cancer Care - Perimeter
Atlanta
404-851-2359


Atlanta Cancer Care - Stockbridge
Lake Spivey


Charles B. Eberhart Cancer Center at DeKalb Medical Center
Decatur
404-851-2340


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Dublin Hematology and Oncology Care
Dublin
478-275-1111


Georgia Health Sciences University Cancer Center
Augusta
706-721-5557


Gwinnett Medical Center
Lawrenceville
404-851-2340


Hamilton Regional Cancer Institute
Dalton


Harbin Clinic Cancer Center
Rome
404-851-2340


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Medical Center of Central Georgia
Macon
478-743-7068


Northeast Georgia Cancer Care, LLC - Athens Medical Oncology
Athens
706-353-2990


Phoebe Cancer Center at Phoebe Putney Memorial Hospital
Albany
800-572-1932


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853


Saint Joseph's Hospital of Atlanta
Atlanta
678-843-7119


Southern Regional Medical Center
Riverdale
770-997-1975


St. Joseph's/Candler Hospital
Savannah
(912) 819-6204


WellStar Cobb Hospital
Austell
770-793-5980


Wellstar Kennestone Hospital
Marietta
770-793-5980

 
NCT01150045 CALGB-80702
CALGB-SWOG-C80702
Colon/Rectal Cancer Phase III Randomized Study of Adjuvant FOLFOX Chemotherapy Comprising Oxaliplatin, Leucovorin Calcium, and Fluorouracil With Versus Without Celecoxib in Patients With Resected Stage III Colon Cancer Atlanta Cancer Care - Alpharetta
Alpharetta
404-851-2359


Atlanta Cancer Care - Conyers
Conyers


Atlanta Cancer Care - Cumming
Cumming


Atlanta Cancer Care - Decatur
Decatur


Atlanta Cancer Care - Perimeter
Atlanta
404-851-2359


Atlanta Cancer Care - Stockbridge
Lake Spivey


Charles B. Eberhart Cancer Center at DeKalb Medical Center
Decatur
404-851-2340


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Dublin Hematology and Oncology Care
Dublin
478-275-1111


Georgia Health Sciences University Cancer Center
Augusta
706-721-5557


Gwinnett Medical Center
Lawrenceville
404-851-2340


Hamilton Regional Cancer Institute
Dalton


Harbin Clinic Cancer Center
Rome
404-851-2340


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Medical Center of Central Georgia
Macon
478-743-7068


Northeast Georgia Cancer Care, LLC - Athens Medical Oncology
Athens
706-353-2990


Pearlman Comprehensive Cancer Center at South Georgia Medical Center
Valdosta
229-259-4628


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853


Saint Joseph's Hospital of Atlanta
Atlanta
678-843-7119


Southern Regional Medical Center
Riverdale
770-997-1975


WellStar Cobb Hospital
Austell
770-793-5980


Wellstar Kennestone Hospital
Marietta
770-793-5980

 
NCT01013649 RTOG-0848
RTOG 0848
Pancreatic Cancer Phase III Randomized Study of Adjuvant Gemcitabine Hydrochloride With Versus Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With Versus Without Chemoradiotherapy With Either Capecitabine or Fluorouracil in Patients With Resected Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Longstreet Cancer Center, PC
Gainesville


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa

 
NCT00956007 RTOG-0920
RTOG-0920
Head and Neck Cancer Phase III Randomized Study of Adjuvant Intensity-Modulated Radiotherapy With Versus Without Cetuximab in Patients With Locally Advanced Resected Squamous Cell Carcinoma of the Head and Neck Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Longstreet Cancer Center, PC
Gainesville


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01274338 ECOG-E1609
E1609
Melanoma Phase III Randomized Study of Adjuvant Ipilimumab Versus High-Dose Recombinant Interferon Alfa-2b in Patients With High-Risk Stage IIIB, IIIC, or IV Melanoma Charles B. Eberhart Cancer Center at DeKalb Medical Center
Decatur
404-851-2340


Emory University Hospital - Midtown
Atlanta
404-686-4411


Georgia Health Sciences University Cancer Center
Augusta
706-721-5557


Gwinnett Medical Center
Lawrenceville
404-851-2340


Harbin Clinic Cancer Center
Rome
404-851-2340


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Medical Center of Central Georgia
Macon
478-743-7068


Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph's/Candler
Savannah
912-819-6204


Northeast Georgia Cancer Care, LLC - Athens Medical Oncology
Athens
706-353-2990


Pearlman Comprehensive Cancer Center at South Georgia Medical Center
Valdosta
229-259-4628


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853


Saint Joseph's Hospital of Atlanta
Atlanta
678-843-7119


Southern Regional Medical Center
Riverdale
770-997-1975


St. Joseph's/Candler Hospital
Savannah
(912) 819-6204


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00026312 COG-ANBL0032
ANBL0032
COG-P9842
Neuroblastoma Phase III Randomized Study of Adjuvant Isotretinoin With or Without Monoclonal Antibody Ch14.18, Interleukin-2, and Sargramostim (GM-CSF) in Patients With Neuroblastoma Who Have Completed Myeloablative Therapy and Autologous Stem Cell Transplantation (Arm Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT01101451 GOG-0263
GOG-0263
Cervical Cancer Phase III Randomized Study of Adjuvant Radiation Versus Chemoradiation Therapy in Patients With Intermediate-Risk Stage I-IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Saint Joseph's Hospital of Atlanta
Atlanta
678-843-7119

 
NCT00103181 NSABP-B-39
RTOG-0413
SWOG-NSABP-B-39
Breast Cancer Phase III Randomized Study of Adjuvant Whole Breast Versus Partial Breast Irradiation in Women With Ductal Carcinoma In Situ or Stage I or II Breast Cancer Atlanta Cancer Care - Alpharetta
Alpharetta
404-851-2359


Atlanta Cancer Care - Conyers
Conyers


Atlanta Cancer Care - Cumming
Cumming


Atlanta Cancer Care - Decatur
Decatur


Atlanta Cancer Care - Perimeter
Atlanta
404-851-2359


Atlanta Cancer Care - Stockbridge
Lake Spivey


Charles B. Eberhart Cancer Center at DeKalb Medical Center
Decatur
404-851-2340


Gwinnett Medical Center
Lawrenceville
404-851-2340


Hamilton Regional Cancer Institute
Dalton


Harbin Clinic Cancer Center
Rome
404-851-2340


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853


Saint Joseph's Hospital of Atlanta
Atlanta
678-843-7119


Southern Regional Medical Center
Riverdale
770-997-1975


WellStar Cobb Hospital
Austell
770-793-5980


Wellstar Kennestone Hospital
Marietta
770-793-5980

 
NCT01368588 RTOG-0924
RTOG-0924
Prostate Cancer Phase III Randomized Study of Androgen-Deprivation Therapy and High-Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Patients With Unfavorable Intermediate- or Favorable High-Risk Prostate Cancer John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Longstreet Cancer Center, PC
Gainesville


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa

 
NCT00408005 COG-AALL0434
AALL0434
Leukemia Phase III Randomized Study of Augmented Berlin-Frankfurt-Münster-86 Multiagent Chemotherapy, Intensified Methotrexate, and Nelarabine in Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Georgia Health Sciences Medical Center - Pediatric Oncology
Augusta

 
NCT00946712 SWOG-S0819
S0819
Lung Cancer Phase III Randomized Study of Carboplatin and Paclitaxel or Carboplatin, Paclitaxel, and Bevacizumab With Versus Without Concurrent Cetuximab in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer Atlanta Cancer Care - Alpharetta
Alpharetta
404-851-2359


Atlanta Cancer Care - Conyers
Conyers


Atlanta Cancer Care - Cumming
Cumming


Atlanta Cancer Care - Decatur
Decatur


Atlanta Cancer Care - Perimeter
Atlanta
404-851-2359


Atlanta Cancer Care - Stockbridge
Lake Spivey


Charles B. Eberhart Cancer Center at DeKalb Medical Center
Decatur
404-851-2340


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Dublin Hematology and Oncology Care
Dublin
478-275-1111


Georgia Health Sciences University Cancer Center
Augusta
706-721-5557


Gwinnett Medical Center
Lawrenceville
404-851-2340


Hamilton Regional Cancer Institute
Dalton


Harbin Clinic Cancer Center
Rome
404-851-2340


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph's/Candler
Savannah
912-819-6204


Northeast Georgia Cancer Care, LLC - Athens Medical Oncology
Athens
706-353-2990


Phoebe Cancer Center at Phoebe Putney Memorial Hospital
Albany
800-572-1932


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853


Saint Joseph's Hospital of Atlanta
Atlanta
678-843-7119


Southern Regional Medical Center
Riverdale
770-997-1975


St. Joseph's/Candler Hospital
Savannah
(912) 819-6204


WellStar Cobb Hospital
Austell
770-793-5980


Wellstar Kennestone Hospital
Marietta
770-793-5980

 
NCT00309985 ECOG-E3805
E3805
Prostate Cancer Phase III Randomized Study of Chemohormonal Therapy Versus Androgen Ablation Therapy in Patients With Extensive Metastatic Prostate Cancer [CHAARTED] Longstreet Cancer Center, PC
Gainesville


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa

 
NCT00655876 RTOG-0436
RTOG 0436
Head and Neck Cancer Phase III Randomized Study of Chemoradiotherapy Comprising Paclitaxel, Cisplatin, and Radiotherapy With Versus Without Cetuximab in Patients With Locally Advanced Esophageal Cancer Emory University Hospital - Midtown
Atlanta
404-686-4411


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Longstreet Cancer Center, PC
Gainesville


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


St. Joseph's/Candler Hospital
Savannah
(912) 819-6204


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01041703 ECOG-E2906
E2906
Leukemia Phase III Randomized Study of Clofarabine Versus Daunorubicin Hydrochloride and Cytarabine Followed by Decitabine Versus Observation in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Georgia Health Sciences University Cancer Center
Augusta
706-721-5557


Saint Joseph's Hospital of Atlanta
Atlanta
678-843-7119

 
NCT00980954 RTOG-0724
RTOG 0724
Cervical Cancer Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiotherapy With Versus Without Adjuvant Chemotherapy in Patients With High-Risk Early-Stage Cervical Carcinoma After Radical Hysterectomy Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Northside Hospital Cancer Institute
Atlanta
404-303-3355


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01406756 COG-AALL1131
AALL1131
Leukemia Phase III Randomized Study of Consolidation Therapy, Interim Maintenance Therapy, Delayed Maintenance Therapy, and Maintenance Therapy in Children, Adolescents, and Young Adults With Newly Diagnosed High-Risk B-precursor Acute Lymphoblastic Leukemia Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT00719303 GOG-0225
GOG-0225
Ovarian Cancer Phase III Randomized Study of Diet and Physical Activity Modification Versus Usual Care in Patients With Previously Treated Stage II, III, or IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Central Georgia Gynecologic Oncology
Macon
476-633-6090


Medical Center of Central Georgia
Macon
478-743-7068

 
NCT01242800 ECOG-E2108
E2108
Breast Cancer Phase III Randomized Study of Early Local Therapy Comprising Surgery Versus Standard Palliative Therapy for the Intact Primary Tumor in Patients With Stage IV Breast Cancer Atlanta Cancer Care - Alpharetta
Alpharetta
404-851-2359


Atlanta Cancer Care - Conyers
Conyers


Atlanta Cancer Care - Cumming
Cumming


Atlanta Cancer Care - Decatur
Decatur


Atlanta Cancer Care - Perimeter
Atlanta
404-851-2359


Atlanta Cancer Care - Stockbridge
Lake Spivey


Charles B. Eberhart Cancer Center at DeKalb Medical Center
Decatur
404-851-2340


Emory University Hospital - Midtown
Atlanta
404-686-4411


Gwinnett Medical Center
Lawrenceville
404-851-2340


Hamilton Regional Cancer Institute
Dalton


Harbin Clinic Cancer Center
Rome
404-851-2340


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853


Saint Joseph's Hospital of Atlanta
Atlanta
678-843-7119


Southern Regional Medical Center
Riverdale
770-997-1975


St. Joseph's/Candler Hospital
Savannah
(912) 819-6204


WellStar Cobb Hospital
Austell
770-793-5980


Wellstar Kennestone Hospital
Marietta
770-793-5980


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01120249 SWOG-S0931
S0931
Kidney Cancer Phase III Randomized Study of Everolimus Versus Placebo in Patients With Renal Cell Carcinoma Who Have Undergone Nephrectomy or Partial Nephrectomy Charles B. Eberhart Cancer Center at DeKalb Medical Center
Decatur
404-851-2340


Georgia Health Sciences University Cancer Center
Augusta
706-721-5557


Gwinnett Medical Center
Lawrenceville
404-851-2340


Harbin Clinic Cancer Center
Rome
404-851-2340


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Pearlman Comprehensive Cancer Center at South Georgia Medical Center
Valdosta
229-259-4628


Phoebe Cancer Center at Phoebe Putney Memorial Hospital
Albany
800-572-1932


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853


Saint Joseph's Hospital of Atlanta
Atlanta
678-843-7119


Southern Regional Medical Center
Riverdale
770-997-1975

 
NCT01012297 GOG-0250
GOG-0250
Uterine Cancer Phase III Randomized Study of Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Patients With Advanced or Recurrent Uterine Leiomyosarcoma Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Georgia Health Sciences University - Gynecologic Oncology
Augusta

 
NCT01041781 CALGB-30801
CALGB-30801
Lung Cancer Phase III Randomized Study of Gemcitabine Hydrochloride or Pemetrexed Disodium in Combination With Carboplatin With Versus Without Celecoxib in Patients With COX-2-Expressing Advanced Non-Small Cell Lung Cancer Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Longstreet Cancer Center, PC
Gainesville


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa

 
NCT00369564 SCUSF-0402
HLMCC-0402
ACCL 0731
Multiple Primaries Phase III Randomized Study of Glutamic Acid in Reducing Vincristine-Related Peripheral Neurotoxicity in Young Patients Undergoing Vincristine-Containing Treatment for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT00382109 COG-ASCT0431
ASCT0431
COG-PBMTC-ONCO51
Acute Lymphoblastic Leukemia Phase III Randomized Study of Graft-Versus-Host Disease Prophylaxis Comprising Tacrolimus and Methotrexate With or Without Sirolimus in Pediatric Patients With Intermediate-Risk or High-Risk Acute Lymphoblastic Leukemia in Second Complete Remission Under  
NCT00336024 COG-ACNS0334
ACNS0334
Brain Cancer Phase III Randomized Study of Induction Chemotherapy Comprising Vincristine, Etoposide, Cyclophosphamide, and Cisplatin With or Without High-Dose Methotrexate and Leucovorin Calcium Followed by Consolidation Chemotherapy Comprising Carboplatin and Thiote Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT00726622 ACOSOG-Z6051
Z6051
Colon/Rectal Cancer Phase III Randomized Study of Laparoscopic-Assisted Resection Versus Open Resection in Patients With Stage IIA, IIIA, or IIIB Rectal Cancer Atlanta Cancer Care - Alpharetta
Alpharetta
404-851-2359


Atlanta Cancer Care - Conyers
Conyers


Atlanta Cancer Care - Cumming
Cumming


Atlanta Cancer Care - Decatur
Decatur


Atlanta Cancer Care - Perimeter
Atlanta
404-851-2359


Atlanta Cancer Care - Stockbridge
Lake Spivey


Charles B. Eberhart Cancer Center at DeKalb Medical Center
Decatur
404-851-2340


Gwinnett Medical Center
Lawrenceville
404-851-2340


Hamilton Regional Cancer Institute
Dalton


Harbin Clinic Cancer Center
Rome
404-851-2340


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853


Saint Joseph's Hospital of Atlanta
Atlanta
678-843-7119


Southern Regional Medical Center
Riverdale
770-997-1975


WellStar Cobb Hospital
Austell
770-793-5980

 
NCT00843882 ECOG-E2905
E2905
Myelodysplastic Syndromes (MDS) Phase III Randomized Study of Lenalidomide With Versus Without Epoetin Alfa in Patients With Low- or Intermediate-1-Risk Myelodysplastic Syndromes and Symptomatic Anemia Georgia Health Sciences University Cancer Center
Augusta
706-721-5557

 
NCT00073528 GSK-EGF30008
UCLA-0311034-01
Breast Cancer Phase III Randomized Study of Letrozole With or Without Lapatinib Ditosylate in Postmenopausal Women With Stage IV Breast Cancer  
NCT00499330 CALGB-140503
CALGB-140503
ECOG-40503
Lung Cancer Phase III Randomized Study of Lobectomy Versus Sublobar Resection in Patients With Small Peripheral Stage IA Non-Small Cell Lung Cancer Emory University Hospital - Midtown
Atlanta
404-686-4411


Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph's/Candler
Savannah
912-819-6204

 
NCT00381680 COG-AALL0433
AALL0433
Acute Lymphoblastic Leukemia Phase III Randomized Study of Low-Dose Versus High-Dose Vincristine and Combination Chemotherapy in Pediatric Patients With Intermediate-Risk Relapsed B-Precursor Acute Lymphoblastic Leukemia(High-Dose Vincristine Closed to Accrual as of 09/2010) Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Georgia Health Sciences Medical Center - Pediatric Oncology
Augusta

 
NCT01107626 ECOG-E5508
E5508
Lung Cancer Phase III Randomized Study of Maintenance Therapy Comprising Bevacizumab Versus Pemetrexed Disodium Versus Bevacizumab and Pemetrexed Disodium Following Induction Therapy With Carboplatin, Paclitaxel, and Bevacizumab in Patients With Advanced Non-Squamo Emory University Hospital - Midtown
Atlanta
404-686-4411


Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph's/Candler
Savannah
912-819-6204


Pearlman Comprehensive Cancer Center at South Georgia Medical Center
Valdosta
229-259-4628


Phoebe Cancer Center at Phoebe Putney Memorial Hospital
Albany
800-572-1932


St. Joseph's/Candler Hospital
Savannah
(912) 819-6204


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01535053 GOG-0275
GOG-0275
Unknown Primary Phase III Randomized Study of Methotrexate Versus Dactinomycin in Patients With Low-Risk Gestational Trophoblastic Neoplasia Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT01279681 NCCTG-N0949
N0949
Colon/Rectal Cancer Phase III Randomized Study of mFOLFOX7 or XELOX Plus Bevacizumab Versus Fluorouracil/Leucovorin Calcium or Capecitabine Plus Bevacizumab as First-Line Therapy in Elderly Patients With Metastatic Colorectal Cancer Longstreet Cancer Center, PC
Gainesville


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


Saint Joseph's Hospital of Atlanta
Atlanta
678-843-7119


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa

 
NCT01385137 SWOG-S0927
S0927
Unknown Primary Phase III Randomized Study of Omega-3-Fatty Acid in Treating Aromatase Inhibitor-Induced Musculoskeletal Pain and Stiffness in Patients With Stage I, II, or IIIA Breast Cancer Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393


Toccoa Cancer Center
Toccoa

 
NCT00954174 GOG-0261
GOG-0261
Uterine Cancer Phase III Randomized Study of Paclitaxel With Carboplatin Versus Ifosfamide in Chemotherapy-Naive Patients With Newly Diagnosed Stage I-IV Persistent or Recurrent Uterine or Ovarian Carcinosarcoma Central Georgia Gynecologic Oncology
Macon
476-633-6090


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Georgia Health Sciences University - Gynecologic Oncology
Augusta


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Medical Center of Central Georgia
Macon
478-743-7068


Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT01575548 ECOG-E2810
E2810
Kidney Cancer Phase III Randomized Study of Pazopanib Hydrochloride in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393

 
NCT00807768 GOG-0249
GOG-0249
Endometrial Cancer Phase III Randomized Study of Pelvic Radiotherapy Versus Vaginal Cuff Brachytherapy, Paclitaxel, and Carboplatin in Patients With High-Risk Stage I or II Endometrial Carcinoma Central Georgia Gynecologic Oncology
Macon
476-633-6090


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Georgia Cancer Center of Excellence at Grady Memorial Hospital
Atlanta
404-489-9000


Georgia Health Sciences University - Gynecologic Oncology
Augusta


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Medical Center of Central Georgia
Macon
478-743-7068


Southeastern Gynecologic Oncology, LLC
Gainesville

 
NCT01302834 RTOG-1016
RTOG-1016
Oral Cancer Phase III Randomized Study of Radiotherapy With Cisplatin or Cetuximab in Patients With Human Papilloma Virus-Associated Oropharyngeal Cancer Longstreet Cancer Center, PC
Gainesville


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853


St. Joseph's/Candler Hospital
Savannah
(912) 819-6204


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00936390 RTOG-0815
RTOG 0815
Prostate Cancer Phase III Randomized Study of Radiotherapy With or Without Short-Term Androgen-Deprivation Therapy in Patients With Intermediate-Risk Prostate Cancer Emory University Hospital - Midtown
Atlanta
404-686-4411


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Longstreet Cancer Center, PC
Gainesville


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393


Northside Hospital Cancer Institute
Atlanta
404-303-3355



Gainesville


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00978458 ECOG-E3F05
E3F05
Brain Cancer Phase III Randomized Study of Radiotherapy With Versus Without Temozolomide in Patients With Symptomatic or Progressive Low-Grade Gliomas Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00769379 NSABP-B-43
NSABP-B-43
Breast Cancer Phase III Randomized Study of Radiotherapy With Versus Without Trastuzumab (Herceptin®) in Women With HER2-Positive Ductal Carcinoma In Situ Who Underwent Lumpectomy Atlanta Cancer Care - Alpharetta
Alpharetta
404-851-2359


Atlanta Cancer Care - Conyers
Conyers


Atlanta Cancer Care - Cumming
Cumming


Atlanta Cancer Care - Decatur
Decatur


Atlanta Cancer Care - Perimeter
Atlanta
404-851-2359


Atlanta Cancer Care - Stockbridge
Lake Spivey


Charles B. Eberhart Cancer Center at DeKalb Medical Center
Decatur
404-851-2340


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Georgia Health Sciences University
Augusta


Gwinnett Medical Center
Lawrenceville
404-851-2340


Hamilton Regional Cancer Institute
Dalton


Harbin Clinic Cancer Center
Rome
404-851-2340


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Longstreet Cancer Center, PC
Gainesville


Medical Center of Central Georgia
Macon
478-743-7068


Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph's/Candler
Savannah
912-819-6204


Northeast Georgia Cancer Care, LLC - Athens Medical Oncology
Athens
706-353-2990


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


Phoebe Cancer Center at Phoebe Putney Memorial Hospital
Albany
800-572-1932


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853


Saint Joseph's Hospital of Atlanta
Atlanta
678-843-7119


Southern Regional Medical Center
Riverdale
770-997-1975


St. Joseph's/Candler Hospital
Savannah
(912) 819-6204


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa


WellStar Cobb Hospital
Austell
770-793-5980


Wellstar Kennestone Hospital
Marietta
770-793-5980


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01196390 RTOG-1010
RTOG-1010
Head and Neck Cancer Phase III Randomized Study of Radiotherapy, Paclitaxel, and Carboplatin With Versus Without Trastuzumab in Patients With HER2-Overexpressing Esophageal Adenocarcinoma Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Longstreet Cancer Center, PC
Gainesville


Medical Center of Central Georgia
Macon
478-743-7068


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853


St. Joseph's/Candler Hospital
Savannah
(912) 819-6204


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa

 
NCT00118209 CALGB-50303
ECOG-50303
NCI-05-C-0252
Non-Hodgkin Lymphoma Phase III Randomized Study of Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) Versus Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin and Rituximab (EPOCH-R) in Patients With Previously Untreated De Novo Di Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph's/Candler
Savannah
912-819-6204


Phoebe Cancer Center at Phoebe Putney Memorial Hospital
Albany
800-572-1932

 
NCT01015833 CALGB-80802
CALGB 80802
Liver Cancer Phase III Randomized Study of Sorafenib Tosylate With Versus Without Doxorubicin Hydrochloride in Patients With Locally Advanced or Metastatic Hepatocellular Carcinoma Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Medical Center of Central Georgia
Macon
478-743-7068


Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph's/Candler
Savannah
912-819-6204


St. Joseph's/Candler Hospital
Savannah
(912) 819-6204

 
NCT01272037 SWOG-S1007
S1007
Breast Cancer Phase III Randomized Study of Standard Adjuvant Endocrine Therapy With Versus Without Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive, and HER2-Negative Breast Cancer Atlanta Cancer Care - Alpharetta
Alpharetta
404-851-2359


Atlanta Cancer Care - Conyers
Conyers


Atlanta Cancer Care - Cumming
Cumming


Atlanta Cancer Care - Decatur
Decatur


Atlanta Cancer Care - Perimeter
Atlanta
404-851-2359


Atlanta Cancer Care - Stockbridge
Lake Spivey


Charles B. Eberhart Cancer Center at DeKalb Medical Center
Decatur
404-851-2340


Dublin Hematology and Oncology Care
Dublin
478-275-1111


Emory University Hospital - Midtown
Atlanta
404-686-4411


Georgia Health Sciences University Cancer Center
Augusta
706-721-5557


Gwinnett Medical Center
Lawrenceville
404-851-2340


Hamilton Regional Cancer Institute
Dalton


Harbin Clinic Cancer Center
Rome
404-851-2340


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Longstreet Cancer Center, PC
Gainesville


Medical Center of Central Georgia
Macon
478-743-7068


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393


Northside Hospital Cancer Institute
Atlanta
404-303-3355



Gainesville


Pearlman Comprehensive Cancer Center at South Georgia Medical Center
Valdosta
229-259-4628


Phoebe Cancer Center at Phoebe Putney Memorial Hospital
Albany
800-572-1932


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853


Saint Joseph's Hospital of Atlanta
Atlanta
678-843-7119


Southern Regional Medical Center
Riverdale
770-997-1975


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa


WellStar Cobb Hospital
Austell
770-793-5980

 
NCT00392327 COG-ACNS0332
ACNS0332
Brain Cancer Phase III Randomized Study of Standard Chemoradiotherapy With or Without Carboplatin Followed by Standard Maintenance Therapy With or Without Isotretinoin and Continuation Therapy With Isotretinoin Versus No Continuation Therapy in Pediatric Patients Wit Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT00020566 EURO-EWING-INTERGROUP-EE99
EBMT-INTERGROUP-EE99
EORTC-62981
GPOH-AUSTRIA-INTERGROUP-EE99
GPOH-GERMANY-INTERGROUP-EE99
SFOP-INTERGROUP-EE99
SWS-SAKK-INTERGROUP-EE99
CCLG-INTERGROUP-EE99
COG-AEWS0331
AEWS0331
EU-20213
Ewing Sarcoma Phase III Randomized Study of Standard Induction Chemotherapy Comprising Vincristine, Dactinomycin, Ifosfamide, and Etoposide Followed By Consolidation Chemotherapy Comprising Vincristine, Dactinomycin, and Ifosfamide Versus High-Dose Busulfan and Melpha  
NCT01336894 ACOSOG-Z4099
ACOSOG-Z4099/RTOG-1021
Lung Cancer Phase III Randomized Study of Sublobar Resection With or Without Brachytherapy Versus Stereotactic Body Radiotherapy in High-Risk Patients With Stage I Non-Small Cell Lung Cancer  
NCT01198145 NCCTG-N08C9
N08C9
Multiple Primaries Phase III Randomized Study of Sulfasalazine for the Prevention of Acute Diarrhea in Patients Undergoing Pelvic Radiotherapy Georgia Health Sciences University
Augusta

 
NCT00693992 CALGB-30607
CALGB 30607
Lung Cancer Phase III Randomized Study of Sunitinib Malate as Maintenance Therapy in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Combination Chemotherapy Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph's/Candler
Savannah
912-819-6204


St. Joseph's/Candler Hospital
Savannah
(912) 819-6204

 
NCT01305200 COG-ACCL1031 Symptom Management Phase III Randomized Study of Supersaturated Calcium Phosphate Rinse to Prevent Oral Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation  
NCT00088166 NTI-0303
BCM-H-14962
Brain Cancer Phase III Randomized Study of Synthetic Human Corticotropin-Releasing Factor to Control Symptoms Associated With Peritumoral Edema in Patients With Malignant Brain Tumors Requiring Chronic Administration of High-Dose Dexamethasone  
NCT00632853 CALGB-30610
CALGB 30610
RTOG 0538
Lung Cancer Phase III Randomized Study of Three Different Thoracic Radiotherapy Regimens in Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Emory University Hospital - Midtown
Atlanta
404-686-4411


Longstreet Cancer Center, PC
Gainesville


Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph's/Candler
Savannah
912-819-6204


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


St. Joseph's/Candler Hospital
Savannah
(912) 819-6204


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01004978 ECOG-E1208
E1208
Liver Cancer Phase III Randomized Study of Transarterial Chemoembolization With Versus Without Sorafenib Tosylate in Patients With Unresectable Hepatocellular Carcinoma Medical Center of Central Georgia
Macon
478-743-7068


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01167712 GOG-0262
GOG-0262
Multiple Primaries Phase III Randomized Study of Two Different Dose Schedules of Paclitaxel in Combination With Carboplatin With Versus Without Concurrent and Consolidation Bevacizumab in Patients With Stage II-IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Ca Central Georgia Gynecologic Oncology
Macon
476-633-6090


Southeastern Gynecologic Oncology, LLC
Gainesville

 
NCT01200589 113676 Non-Hodgkin Lymphoma Phase III Randomized, Open Label Study of Single Agent Ofatumumab Vs. Single Agent Rituximab in Follicular Lymphoma Relapsed After Rituximab-Containing Therapy Central Georgia Cancer Care, PC - Macon
Macon


Central Georgia Cancer Care, PC - Warner Robins
Warner Robins


Northwest Georgia Oncology Centers, PC - Austell
Austell


Northwest Georgia Oncology Centers, PC - Carrollton
Carrollton


Northwest Georgia Oncology Centers, PC - Cartersville
Cartersville


Northwest Georgia Oncology Centers, PC - Douglasville
Douglasville


Northwest Georgia Oncology Centers, PC - Marietta
Marietta
770-281-5131

 
NCT00352534 COG-AREN0532
AREN0532
Wilms Tumor Phase III Study of Adjuvant Vincristine, Dactinomycin and Doxorubicin Hydrochloride With or Without Radiotherapy or Observation Only in Younger Patients Who are Undergoing Nephrectomy for Newly Diagnosed Stage I-III Favorable Histology Wilms' Tumor Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Georgia Health Sciences Medical Center - Pediatric Oncology
Augusta

 
NCT00945009 COG-AREN0534
AREN0534
Wilms Tumor Phase III Study of Combination Chemotherapy and Surgery in Young Patients With Bilateral, Multicentric, or Bilaterally Predisposed Unilateral Wilms Tumor Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT00980460 COG-AHEP0731
AHEP0731
Liver Cancer Phase III Study of Combination Chemotherapy in Pediatric Patients With Newly Diagnosed Hepatoblastoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT00379340 COG-AREN0533
AREN0533
Wilms Tumor Phase III Study of Combination Chemotherapy With or Without Radiotherapy in Patients With Newly Diagnosed Stage III or IV Favorable Histology Wilms Tumor Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT01547741 NSABP-B-49
NSABP-B-49
Breast Cancer Phase III Study of Docetaxel and Cyclophosphamide Versus Anthracycline-Based Chemotherapy Regimens in Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393


Pearlman Comprehensive Cancer Center at South Georgia Medical Center
Valdosta
229-259-4628


Toccoa Cancer Center
Toccoa

 
NCT00653068 COG-ACNS0333
ACNS0333
Brain Cancer Phase III Study of Induction Therapy Comprising Vincristine, High-Dose Methotrexate, Leucovorin Calcium, Etoposide, Cisplatin, and Cyclophosphamide Followed by 3-Dimensional Conformal Radiotherapy and High-Dose Consolidation Therapy Comprising Carboplatin Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT00554788 COG-ARET0321
ARET0321
Retinoblastoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01311063 RTOG0920-VA
RAC# 2101-074
Head and Neck Cancer Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally Advanced Resected Head and Neck Cancer Veterans Affairs Medical Center - Atlanta
Decatur
404-728-7680

 
NCT01546987 CDR0000727326
RTOG-1115
Prostate Cancer Phase III Trial of Dose Escalated Radiation Therapy and Standard Androgen Deprivation Therapy (ADT) With a GNRH Agonist vs. Dose Escalated Radiation Therapy and Enhanced ADT With a GNRH Agonist and TAK-700 For Men With High Risk Prostate Cancer Emory University Hospital - Midtown
Atlanta
404-686-4411


Georgia Cancer Center of Excellence at Grady Memorial Hospital
Atlanta
404-489-9000


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01125566 1200.75
2009-015476-98
Breast Cancer Phase III Trial of Vinorelbine+ BIBW 2992 vs Vinorelbine+Herceptin in BC Patients After Failing Herceptin Treatment Suburban Hematology-Oncology Associates, PC - Duluth
Duluth


Suburban Hematology-Oncology Associates, PC - Lawrenceville
Lawrenceville
678-533-1559


Suburban Hematology-Oncology Associates, PC - Snellville
Snellville

 
NCT01696084 CLTR0310-301 Leukemia PHASE III, MULTICENTER, RANDOMIZED, TRIAL OF CPX-351 (CYTARABINE:DAUNORUBICIN) LIPOSOME INJECTION VERSUS CYTARABINE AND DAUNORUBICIN IN PATIENTS 60-75 YEARS OF AGE WITH UNTREATED HIGH RISK (SECONDARY) AML. Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT01007448 E7273-G000-401 Lymphoma Phase IV Randomized Study Of Two Dose Levels Of Targretin~ Capsules In Patients With Refractory Cutaneous T-Cell Lymphoma  
NCT00772200 COG-ALTE07C1
ALTE07C1
Brain Cancer Pilot Study of Neuropsychological and Behavioral Assessment in Children With Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor (PNET) Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT01055314 COG-ARST08P1
ARST08P1
Rhabdomyosarcoma Pilot Study of Temozolomide and Cixutumumab in Combination With Intensive Multi-Agent Interval Compressed Chemotherapy in Patients With High-Risk Metastatic Rhabdomyosarcoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT00086762 MDA-CCC-0106
MDA-2004-0024
Symptom Management Pilot, Randomized Study of Mindfulness Relaxation Versus Relaxing Music Versus Standard Symptom Management Education in Patients With Newly Diagnosed Solid Tumors Undergoing Chemotherapy Atlanta Cancer Care - Alpharetta
Alpharetta
404-851-2359


Atlanta Cancer Care - Conyers
Conyers


Atlanta Cancer Care - Cumming
Cumming


Atlanta Cancer Care - Decatur
Decatur


Atlanta Cancer Care - Perimeter
Atlanta
404-851-2359


Atlanta Cancer Care - Stockbridge
Lake Spivey


Charles B. Eberhart Cancer Center at DeKalb Medical Center
Decatur
404-851-2340


Gwinnett Medical Center
Lawrenceville
404-851-2340


Hamilton Regional Cancer Institute
Dalton


Harbin Clinic Cancer Center
Rome
404-851-2340


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853


Saint Joseph's Hospital of Atlanta
Atlanta
678-843-7119


Southern Regional Medical Center
Riverdale
770-997-1975


WellStar Cobb Hospital
Austell
770-793-5980

 
NCT01567462 PK Button and Bladder Tumors Bladder Cancer PK Button Vaporization Electrode for Treatment of Bladder Tumors Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01007890 PT-304 Breast Cancer Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer  
NCT01152268 SBANK10 Multiple Primaries Predictors of Adolescent Sperm Banking:Development of a Profiling and Referral Tool  
NCT00651976 VICC BRE 0776
P50CA098131
P30CA068485
VU-VICC-BRE-0776
VU-VICC-IRB-080064
Breast Cancer Pre-Surgical Trial of Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer (Spore) Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01319838 Aflac ST1001 Neuroblastoma Prolonged Isotretinoin Therapy in Patients With High Risk Neuroblastoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01539993 00014768 Liver Cancer Prospective Analysis of Liver Cancer Treatment and Interventions Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01563679 RAD2160-11 Unknown Primary Prospective Analysis of Percutaneous Ablations for Cancer Treatment Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00907634 EmoryCervicalMotion Cervical Cancer Prospective Evaluation of Intrafractional and Interfractional Cervical Motion During External Beam Radiation for Intact Cervical Cancer by the Calypso® 4D Localization System™  
NCT01479101 P0339 NBRST Registry Breast Cancer Prospective Neo-adjuvant REGISTRY Trial Linking MammaPrint, Subtyping and Treatment Response: Neoadjuvant Breast Registry - Symphony Trial (NBRST) (Pronounced "in Breast") Advanced Breast Care of Georgia
Marietta

 
NCT00874211 SWOG-S0702
S0702
Symptom Management Prospective Observational Study of the Incidence of Osteonecrosis of the Jaw in Cancer Patients with Bone Metastases Receiving Zoledronic Acid Atlanta Cancer Care - Alpharetta
Alpharetta
404-851-2359


Atlanta Cancer Care - Conyers
Conyers


Atlanta Cancer Care - Cumming
Cumming


Atlanta Cancer Care - Decatur
Decatur


Atlanta Cancer Care - Perimeter
Atlanta
404-851-2359


Atlanta Cancer Care - Stockbridge
Lake Spivey


Charles B. Eberhart Cancer Center at DeKalb Medical Center
Decatur
404-851-2340


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Georgia Health Sciences University
Augusta


Gwinnett Medical Center
Lawrenceville
404-851-2340


Hamilton Regional Cancer Institute
Dalton


Harbin Clinic Cancer Center
Rome
404-851-2340


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Longstreet Cancer Center, PC
Gainesville


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


Pearlman Comprehensive Cancer Center at South Georgia Medical Center
Valdosta
229-259-4628


Phoebe Cancer Center at Phoebe Putney Memorial Hospital
Albany
800-572-1932


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853


Saint Joseph's Hospital of Atlanta
Atlanta
678-843-7119


Southern Regional Medical Center
Riverdale
770-997-1975


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa


WellStar Cobb Hospital
Austell
770-793-5980


Wellstar Kennestone Hospital
Marietta
770-793-5980

 
NCT01617954 PROMIS Breast Cancer Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score Charles B. Eberhart Cancer Center at DeKalb Medical Center
Decatur
404-851-2340


Northeast Georgia Cancer Care, LLC - Athens Medical Oncology
Athens
706-353-2990


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393

 
NCT01366183 GOG-0273
GOG-0273
Ovarian Cancer Prospective Study of Chemotherapy Toxicity in Elderly Patients With Stage I-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT00899093 GOG-0235
GOG-0235
Gynecologic Cancers Prospective Study of YKL-40 in Patients With Newly Diagnosed Stage III or IV Invasive Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Undergoing Primary Chemotherapy Central Georgia Gynecologic Oncology
Macon
476-633-6090


Medical Center of Central Georgia
Macon
478-743-7068

 
NCT01110733 COMPLETE Registry Leukemia Prospective, Longitudinal, Multinational Registry of Patients With Newly Diagnosed Peripheral T-Cell Lymphoma
Lithonia



Marietta



Macon



Atlanta
404-256-4777



Decatur

 
NCT01166009 NMDP IRB-1999-0021 Hematologic Malignancies Protocol For A Research Database For Hematopoietic Stem Cell Transplantation and Marrow Toxic Injuries Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT01117168   Multiple Primaries Protocol for the Enrollment on the Official COG Registry, The Childhood Cancer Research Network (CCRN) Children's Oncology Group Georgia Health Sciences Medical Center - Pediatric Oncology
Augusta

 
NCT01091428 C14008 Breast Cancer Randomized Phase 2 Study of MLN8237, an Aurora A Kinase Inhibitor, Plus Weekly Paclitaxel or Weekly Paclitaxel Alone in Patients With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, Preceded by a Phase 1 Portion in Patients Wit Georgia Health Sciences University - Gynecologic Oncology
Augusta

 
NCT00912340 WCI1524-08 Breast Cancer Randomized Phase II of Trastuzumab With and Without Everolimus in Hormone-Refractory Metastatic Breast Cancer Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00892710 SCRI LUN 196 Lung Cancer Randomized Phase II Trial of Pemetrexed vs. Pemetrexed/Bevacizumab vs. Pemetrexed/Carboplatin/Bevacizumab in Patients With Stage IIIB/IV Non-Small-Cell Lung Cancer and ECOG Performance Status 2 Longstreet Cancer Center, PC
Gainesville


Northeast Georgia Medical Center - Gainesville
Gainesville
770-535-3393



Gainesville


Surgical Oncology of Northeast Georgia
Gainesville


Toccoa Cancer Center
Toccoa

 
NCT00415285 EU822-03 Breast Cancer Randomized Phase II Trial of Sequential Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine as in Induction Therapy for Early Stage Breast Cancer  
NCT00336089 CSU-GCC-161 Breast Cancer Randomized Study of an Exercise Program Comprising Cardiorespiratory and Resistance Training (Cross Training) Versus a Health Education Program in Reducing Fatigue and Pain Levels in Breast Cancer Survivors  
NCT01238172 CALGB-70807
CALGB 70807
Prostate Cancer Randomized Study of Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance Charles B. Eberhart Cancer Center at DeKalb Medical Center
Decatur
404-851-2340


Gwinnett Medical Center
Lawrenceville
404-851-2340


Harbin Clinic Cancer Center
Rome
404-851-2340


John B. Amos Cancer Center - Columbus Regional Healthcare System
Columbus
706-660-6449


Piedmont Fayette Hospital
Fayetteville
404-851-2340


Piedmont Hospital - Atlanta
Atlanta
404-851-2340


Piedmont Hospital Research Institute at Piedmont Hospital
Atlanta
404-350-9853


Saint Joseph's Hospital of Atlanta
Atlanta
678-843-7119


Southern Regional Medical Center
Riverdale
770-997-1975


WellStar Cobb Hospital
Austell
770-793-5980


Wellstar Kennestone Hospital
Marietta
770-793-5980

 
NCT01439945 NCCTG-N10C2
N10C2
Breast Cancer Randomized Study of Magnesium Oxide in Postmenopausal Women With Hot Flashes and a History of Breast Cancer Georgia Health Sciences University
Augusta

 
NCT00953082 FCCC-07848
07-848
Unspecified Randomized Study of Parent Social-Cognitive Intervention Program (P-SCIP) Versus Best-Recommended Psychosocial Care (BPC) in Facilitating Parent Adaptation to Pediatric Hematopoietic Stem Cell Transplantation  
NCT01515800 SWOG-S1105
S1105
Breast Cancer Randomized Study of Text-Messaging Intervention in Reducing Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Stage I, II, or III Breast Cancer Dwight David Eisenhower Army Medical Center
Fort Gordon
706-787-2100

 
NCT01259856 MPD-RC 112
P01CA108671
Myelodysplastic Syndromes (MDS) Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea Therapy in the Treatment of High Risk Polycythemia Vera (PV) and High Risk Essential Thrombocythemia (ET) Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01560104 M10-898
2011-003427-36
Lung Cancer Randomized, Double-Blind, Multicenter, Phase 2 Trial Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Metastatic or Advanced Non-Small-Cell Lung Cancer (NSCLC) Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01418222 GO27827 Colon/Rectal Cancer Randomized, Double-Blind, Phase II Study of FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment for Patients With Metastatic Colorectal Cancer
Atlanta
404-256-4777

 
NCT01611090 CR100840
PCI-32765CLL3001
2012-000600-15
Leukemia Randomized, Double-blind, Placebo-controlled Phase 3 Study of Ibrutinib, a Bruton's Tyrosine Kinase (BTK) Inhibitor, in Combination With Bendamustine and Rituximab (BR) in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Peachtree Hematology-Oncology Consultants, PC - Atlanta
Atlanta
678-298-3235


Peachtree Hematology-Oncology Consultants, PC - Fayetteville
Fayetteville

 
NCT01450761 CA184-156
2011-000850-48
Lung Cancer Randomized, Multicenter, Double-Blind, Phase 3 Trial Comparing the Efficacy of Ipilimumab Plus Etoposide/Platinum Versus Etoposide/Platinum in Subjects With Newly Diagnosed Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) Medical Oncology Associates, PC
Augusta
706-722-4245

 
NCT01391130 14241
I2V-MC-CXAB
Kidney Cancer Randomized, Multicenter, Open-label, Active-Controlled, Phase 2 Study of LY2510924 and Sunitinib Versus Sunitinib in Patients With Metastatic Renal Cell Carcinoma Suburban Hematology-Oncology Associates, PC - Duluth
Duluth


Suburban Hematology-Oncology Associates, PC - Lawrenceville
Lawrenceville
678-533-1559


Suburban Hematology-Oncology Associates, PC - Snellville
Snellville

 
NCT01712009 20110147 Breast Cancer Randomized, Phase 2 Study to Estimate the Effect of Prophylactic Intervention With Naproxen or Loratadine on Bone Pain in Breast Cancer Subjects Receiving Chemotherapy and Pegfilgrastim  
NCT00941330 WCI1534-08 Breast Cancer Randomized, Phase II Trial of Pre-Operative Docetaxel-Cytoxan (TC) or Exemestane in Patients With Hormone Receptor-Positive Breast Cancers With Recurrence Scores Less Than 25 (= 24) Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
Caris Caris Multiple Primaries Registry of patients that have received the Caris Target Now and/or hematopoietic diagnostic testing  
NCT00899275 COG-AOST06B1
AOST06B1
Bone and Soft Tissue (including Sarcoma) Repository Study of Blood and Tumor Tissue Samples From Patients With Osteosarcoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT00904241 COG-ANBL00B1
ANBL00B1
Neuroblastoma Research Study of Clinical, Genetic, and Biological Factors as Prognostic Values in Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Georgia Health Sciences Medical Center - Pediatric Oncology
Augusta

 
NCT00897442 GOG-0136 Multiple Primaries Research Study of Collection of Gynecological Tumor Specimens Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT00967096 Rifaximin Lymphoma Rifaximin for Preventing Acute Graft Versus Host Disease  
NCT00598169 CDR0000581078
U01CA121947
AMC-053
Lymphoma Safety and Efficacy Pilot Trial of the Anti-Viral and Anti-Tumor Activity of Velcade Combined With (R)ICE in Subjects With EBV and/or HHV-8 Positive Relapsed/Refractory AIDS-Associated Non-Hodgkin's Lymphoma Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01012492 Abatacept Myelodysplastic Syndromes (MDS) Safety and Tolerability Trial of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor Hematopoietic Stem Cell Transplant Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01317056 RTOG 0813 Lung Cancer Seamless Phase I/II Study Of Stereotactic Lung Radiotherapy (SBRT) For Early Stage, Centrally Located, Non-Small Cell Lung Cancer (NSCLC) In Medically Inoperable Patients Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT01259817 GCO 09-1300 001
P01CA108671
MPD-RC 111
Myelodysplastic Syndromes (MDS) Single Arm Salvage Therapy With Pegylated Interferon Alfa-2a for Patients With High Risk Polycythemia Vera or High Risk Essential Thrombocythemia Who Are Either Hydroxyurea Resistant or Intolerant or Have Had Abdominal Vein Thrombosis Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01331135 Aflac ST0901 CHOANOME Multiple Primaries Sirolimus in Combination With Metronomic Therapy in Children With Recurrent and Refractory Solid Tumors: A Phase I Study Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01272557 SoraDox Liver Cancer Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial  
NCT00897325 COG-AALL05B1
AALL05B1
Leukemia Specimen Collection and Banking From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01554969 STA 9090 Colon/Rectal Cancer STA9090: Phase I Trial of Ganetespib, Capecitabine, and Radiation in Rectal Cancer Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT00898079 COG-ABTR01B1
ABTR01B1
Leukemia Study of Collection and Banking of Malignant, Borderline Malignant Neoplasms, and Related Biological Specimens from Young Patients With Cancer Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913

 
NCT00382005 ECOG-E3A05
E3A05
Non-Hodgkin Lymphoma Study of Bone Marrow and Blood Sample Collection Before Treatment in Patients With Multiple Myeloma or Other Plasma Cell Disorders  
NCT00919750 COG-ACNS02B3
ACNS02B3
Germ Cell Tumor Study of Collection and Banking of Specimens From Pediatric Patients With Brain Tumors Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451


Georgia Health Sciences Medical Center - Pediatric Oncology
Augusta

 
NCT00690469 COG-AEPI05N1
AEPI05N1
Retinoblastoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01407770 WFU-97609
CCCWFU 97609
Breast Cancer Study of Genetic Susceptibility and Exposure on Radiation-Induced Acute and Chronic Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer Georgia Health Sciences University
Augusta

 
NCT00082745 COG-ALTE03N1
ALTE03N1
Multiple Primaries Study of Key Late-Occurring Complications in Childhood Cancer Survivors Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Georgia Health Sciences Medical Center - Pediatric Oncology
Augusta

 
NCT00736749 COG-ALTE05N1
ALTE05N1
Multiple Primaries Study of Long-Term Follow-Up in Patients Who Have Participated in Children's Oncology Group Studies Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215

 
NCT00897039 SEG-20060042
SEG-IRB-1075624
Ovarian Cancer Study of Microculture Kinetic Assay in Determining Drug Sensitivity of Tumor Cells of Patients Undergoing Chemotherapy for Ovarian, Fallopian Tube, or Primary Peritoneal Adenocarcinoma Southeastern Gynecologic Oncology - Northside
Atlanta
678-420-4154

 
NCT00437060 COG-AALL06N1
AALL06N1
Acute Lymphoblastic Leukemia Study of Neurocognitive Function in Children Receiving Methotrexate for Acute Lymphoblastic Leukemia Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT00898365 COG-AREN03B2
AREN03B2
Kidney Cancer Study of Renal Tumors in Pediatric Patients Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Georgia Health Sciences Medical Center - Pediatric Oncology
Augusta

 
NCT01142427 COG-AALL08B1
AALL08B1
Leukemia Study of Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01556256 COG-ANUR1131
ANUR1131
Unknown Primary Study of Therapeutic Music Video Intervention in Improving Communication and Resilience in Adolescents/Young Adults Undergoing Treatment for High-Risk Cancer and Their Parents Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853

 
NCT00959283 COG-AAML08B1
AAML08B1
Acute Myelogenous Leukemia Study of Transient Myeloproliferative Disorder in Peripheral Blood Samples From Newborns With Down Syndrome Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT00919269 COG-D9902
IRS-D9902
CCG-B904
POG-9153
D9902
Bone and Soft Tissue (including Sarcoma) Study to Collect and Characterize Tissue Specimens From Patients With Rhabdomyosarcoma Or Non-Rhabdomyosarcoma Soft Tissue Sarcoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451


Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center
Savannah
912-350-8913


Georgia Health Sciences Medical Center - Pediatric Oncology
Augusta

 
NCT00899223 CALGB-9665 Leukemia Study to Collect and Store Specimens From Patients With Previously Untreated Acute or Chronic Leukemia or Myelodysplastic Syndromes  
NCT01244750 CA180-330 Leukemia Studying Interventions for Managing Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase: The 5-Year Prospective Cohort Study (SIMPLICITY)
Atlanta
404-256-4777


Lewis Hall Singletary Oncology Center at John D. Archbold Memorial Hospital
Thomasville


Northwest Georgia Oncology Centers, PC - Austell
Austell


Northwest Georgia Oncology Centers, PC - Carrollton
Carrollton


Northwest Georgia Oncology Centers, PC - Cartersville
Cartersville


Northwest Georgia Oncology Centers, PC - Douglasville
Douglasville


Northwest Georgia Oncology Centers, PC - Marietta
Marietta
770-281-5131


Peachtree Hematology-Oncology Consultants, PC - Atlanta
Atlanta
678-298-3235


Peachtree Hematology-Oncology Consultants, PC - Fayetteville
Fayetteville

 
NCT00375674 A6181109 Kidney Cancer Sunitinib Treatment Of Renal Adjuvant Cancer (S-TRAC): A Randomized Double Blind Phase 3 Study Of Adjuvant Sunitinib VS. Placebo In Subjects At High Risk Of Recurrent RCC  
NCT01186328 T2009-007 Acute Lymphoblastic Leukemia T2009-007: A Phase I Study Evaluating the Safety, Tolerability and Biological Activity of EZN-3042, a Survivin mRNA Antagonist, Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [IND 108753] Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01492101 11-PIR-11 Breast Cancer The BEACON Study (Breast Cancer Outcomes With NKTR-102): A Phase 3 Open-Label, Randomized, Multicenter Study of NKTR-102 Versus Treatment of Physician's Choice (TPC) in Patients With Locally Recurrent or Metastatic Breast Cancer Previously Treated With an Northwest Georgia Oncology Centers, PC - Austell
Austell


Northwest Georgia Oncology Centers, PC - Carrollton
Carrollton


Northwest Georgia Oncology Centers, PC - Cartersville
Cartersville


Northwest Georgia Oncology Centers, PC - Douglasville
Douglasville


Northwest Georgia Oncology Centers, PC - Marietta
Marietta
770-281-5131


Peachtree Hematology-Oncology Consultants, PC - Atlanta
Atlanta
678-298-3235


Peachtree Hematology-Oncology Consultants, PC - Fayetteville
Fayetteville


Summit Cancer Care
Savannah
912-354-6187


Summit Cancer Care - Statesboro
Statesboro


Summit Cancer Care at Curtis and Elizabeth Anderson Cancer Institute
Savannah


Summit Cancer Care at the Nancy N. Lewis and J.C. Lewis Cancer & Research Pavilion
Savannah

 
NCT01499394 TCBIO-001-0710 Unknown Primary The Caris Biorepository Research Protocol Phoebe Cancer Center at Phoebe Putney Memorial Hospital
Albany
800-572-1932


Southeastern Urology Associates
Macon
478-742-0932

 
NCT01084694 NSH 888 Quality of Life The Impact of Hematopoietic Stem Cell Transplantation on Primary Caregiver Level of Burden and Distress Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT01547845 999912039
12-C-N039
Breast Cancer The NCl Community Cancer Center Program Patients Reported Symptom Surveillance and Disparities Study Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph's/Candler
Savannah
912-819-6204


Northside Hospital Cancer Institute
Atlanta
404-303-3355

 
NCT00900250 COG-AHOD04B1
AHOD04B1
Hodgkin Lymphoma Tissue Bank/Repository Study of Biologic Specimens From Children and Young Adults With Hodgkin's Lymphoma Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01447732 CEP-37250/KHK2804-001 Unknown Primary Two-Part, Open-Label, Multi-Center Phase 1 Study of Monoclonal Antibody CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01146366 08-0020 Lung Cancer Utility of Routine Cervical Mediastinoscopy in Clinically Staged T2N0M0 and Select T1N0M0 Non-Small Cell Lung Cancers by FDG-PET and CT Scans  
NCT01526486 IRB00012329 Gynecologic Cancers Videoscopic Versus Open Inguinal Lymphadenectomy for Sentinel Node Positive Cutaneous Malignancies and Genitourinary Staging Procedures Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01019850 CDR0000659059
P01CA081403
N2007-03
NANT-N2007-03
Neuroblastoma Vorinostat With 131-I MIBG Therapy for Resistant/Relapsed Neuroblastoma: A Phase I Study IND# 105,744 Aflac Cancer and Blood Disorders Center of Children’s at Egleston
Atlanta
404-785-0853


Aflac Cancer and Blood Disorders Center of Children’s at Scottish Rite
Atlanta
404-785-2215


Children's Healthcare of Atlanta - Egleston
Atlanta
404-727-4451

 
NCT01194869 WCI1590-08 Breast Cancer WCI1590-08: Phase II Neoadjuvant Trial of Sorafenib in Combination With Cisplatin Followed by Dose Dense Paclitaxel for ER-, PR-, Her2- (Triple Negative) Early-Stage Breast Cancer Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01435395 WCII1837-10 Brain Cancer WCI1837-10: Phase I Trial of Temozolomide, Bevacizumab Plus Bortezomib for Patients With Recurrent Glioblastoma Multiforme Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01445691 WCI1999-11 Brain Cancer WCI1999-11: A Phase II Study of 5-Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Newly Diagnosed or Recurrent Malignant Gliomas Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 
NCT01469572 WCI2031-11 Metastases WCI2031-11: Phase IB/II Study of Pasireotide, Everolimus and Selective Internal Radioemobilization Therapy (SIRT) for Unresectable Neuroendocrine Hepatic Metastases Emory University Hospital - Midtown
Atlanta
404-686-4411


Winship Cancer Institute of Emory University
Atlanta
404-778-5180

 

Recent Facebook Activity

Contact Us






Recent Tweets